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ABSTRACT
Cancer is a major public health problem worldwide. An estimated 1.6 million new cases
of cancer will be diagnosed in the United States in 2017. Most cancers are assumed to
develop from the initiation of chemically induced DNA damages. Chemical carcinogens
are genotoxic and they undergo enzymatic activation into reactive electrophilic species
to form covalent bonds with the electron-rich DNA that form adducts. Aromatic amines
are one of the most examined chemical carcinogens, and once activated, these amines
attack the C-8 position of guanine to form C8-dG adducts (ABP [N-(2′-deoxyguanosin8-yl)-2-aminobiphenyl], AF [N-(2′-deoxyguanosin-8-yl)-2-aminofluorene], and AAF
[N-(2′-deoxyguanosin-8-yl)-2-acetylaminofluorene]); these formations result in DNA
lesions. These bulky DNA lesions at the replication fork can induce a conformational
heterogeneity, which complicates mutational outcomes. These outcomes are due to a
single DNA adduct that can adopt multiple conformations at the replication fork, and a
polymerase may process each conformation in different ways. Studies have shown
differences in the mutational consequences of arylamine adducts in different DNA
sequences. AF, AAF, and ABP all adopt anti B-DNA , syn stacked (S), and wedge (W)
DNA conformational heterogeneity depending on sequence contexts. A replication
polymerase is likely to stall or completely stop DNA synthesis when it encounters a
bulky DNA lesion; this outcome allows recruitment of various bypass polymerases.
This move will determine whether the synthesis is to be error free or error prone.
Understanding the processes involving replication polymerases in arylamine-induced
translesion synthesis is important; these processes are implicated in mutation and repair.

Our working hypothesis is that the sequence-dependent arylamine-conformational
heterogeneity is an important consideration for its mutational and repair outcomes. In
Manuscript I (to be submitted to Journal of Chemical Research in Toxicology), we
explored the arylamine-conformational heterogeneity. We previously reported a 3′-next
flanking sequence effect [G*CT vs. G*CA; G*, FABP, N-(2′-deoxyguanosin-8-yl)-4′fluoro-4-aminobiphenyl; FAF, N-(2′-deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene]
on arylamine-DNA lesions in relation to DNA replication and repair. In the present
study, we present an unusual sequence effect on a 16-mer fully paired DNA duplex 5′CTTCTG1G2TCCTCATTC-3′, in which the same lesion modification at G 1 and G2
revealed a dramatic difference in S (base-displaced stacked)/B (major groove binding
B-type) conformational heterogeneity. We obtained conformational ( 19F-NMR/CD),
calorimetric (DSC and ITC), and binding (SPR) data for a set of four 16-mer modified
templates (FABP vs. FAF and TG1*G2T vs. TG1G2*T) during primer elongation.
Dynamic
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F-NMR results indicate that FABP modification at G1 and G2 resulted in

67%:33% of B:S and 100% B population ratios, respectively, and the planar FAF in the
same sequence contexts exhibited 25%:75% B:S and 83%:17% B:S, respectively. A
significant increase was observed in S-conformation (0% to 17%) going from a twisted
nonplanar FABP to a planar FAF. Calorimetric (DSC and ITC) and UV-melting data
revealed that the B-conformer is a thermodynamic stabilizer in duplex settings, and the
S-conformer is a destabilizer. The situation is reversed during the primer elongation
process that involves ss/ds duplexes, i.e., S-conformation promotes lesion stacking at
the ss/ds replication fork. This finding is in agreement with SPR binding results, which
showed that lesion stacking increases the binding affinity of the complementary strands

in the order of FABP > FAF and G*GT > GG*T. Surprisingly, our data revealed that
the twisted biphenyl is a better stacker at ss/ds junction than the coplanar FAF, possibly
due to its ring flexibility that helps accommodate the replication fork structures. This
finding is not the case for fully paired duplexes in which base-displaced stacking is
enhanced by lesion planarity. The extent of primer dissociation rates across the lesion
was influenced by the DNA sequences and the nature of the lesion (FAF vs. FABP).
These results provide conformational insights into the important role of ss/ds sequence
effects in modulating bulky lesion-induced translesion DNA synthesis. Manuscript II
(to be submitted to Journal of Nature Structural & Molecular Biology) is the extension
of manuscript I. Bulky organic carcinogens are usually activated in vivo and form DNA
adducts. Some of these DNA adducts exist in multiple conformations that are slowly
interconverted to one another. For example, the dG-C8-lesion of the human bladder
carcinogen 4-aminobiphenyl (ABP) has been reported to exist in a sequence-dependent
mixture of B/S conformations. Different conformations have been shown to lead to
different kinetic capacities, binding capacities, and ultimately different translesion
synthesis and transcription capacities. Although rare, conformation-dependent
mutagenic and repair patterns have been reported. For example, the bulky Nacetylaminofluorene at G3 in the NarI sequence (5′-G1G2CG3CN-3′) induces a high
frequency of −2 frameshift mutations, whereas the adducts on G 1 and G2 are not
mutagenic. Results show why mutagenic hotspots exist in the genome. However, the
conformation-specific replication block, which is more relevant to replication, has not
been reported. Such research deficiency may be due to the dynamicity of the replication
block process. As such, the replication block becomes difficult to capture by current

end-point assays, which usually detect either the ensemble of consequence of all the
conformers or the culmination of all cellular behaviors, such as mutagenicity or survival
rate. In Manuscript I, we showed very unusual sequence-dependent conformational
heterogeneities involving FABP-modified DNA under different sequence contexts
(TG1*G2T [67%B:33%S] and TG1G2*T [100%B], G*, FABP, N-(2′-deoxyguanosin-8yl)-4′-fluoro-4-aminobiphenyl). Different biological consequences are believed to be
linked to different adducts. In the present study, we attempted to correlate the replication
block to different conformations from the single FABP-modified DNA lesion. We
utilized a combination of biophysical (SPR and steady-state kinetics) tools to reveal the
differences in vitro. The results were discussed in terms of conformational differences.
Manuscript III (has been accepted by Journal of ACS Omega) is a technical paper. We
focused on the oligonucleotides. Oligonucleotides serve as important tools for
biological, chemical, and medical research.

The preparation of oligonucleotides

through automated solid-phase synthesis is well established. However, identification of
byproducts generated from DNA synthesis, especially from oligonucleotides containing
site-specific modifications, is sometimes challenging.

Typical HPLC, Mass

Spectrometry (MS), and gel electrophoresis methods alone are not sufficient for
characterizing unexpected byproducts, especially for those having identical or very
similar molecular weight (MW) to the products. We used a rigorous quality control
procedure to characterize byproducts generated during oligonucleotide syntheses: 1)
purify oligonucleotide by different HPLC systems; 2) determine the exact MW by high
resolution MS; 3) locate modification position by MS/MS or exonuclease digestion with
MALDI-TOF analysis; and 4) conduct, where applicable, enzymatic assays. We applied

these steps to characterize byproducts in the syntheses of oligonucleotides containing
important methyl DNA adducts 1-methyladenine (m1A) and 3-methylcytosine (m3C).
In m1A synthesis, we differentiated a regioisomeric byproduct 6-methyladenine, which
possesses identical MW to m1A. As for m3C, we identified a deamination byproduct
3-methyluracil, which is only 1 Dalton greater than m3C in the ~ 4,900 Dalton context.
The detection of these byproducts would be very challenging if the abovementioned
procedure were not adopted.
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ABSTRACT
DNA damage by bulky organic lesions can affect DNA replication and repair
efficiencies. We previously reported a 3′-next flanking sequence effect [G*CT vs.
G*CA; G*, FABP, N-(2′-deoxyguanosin-8-yl)-4′-fluoro-4-aminobiphenyl; FAF, N-(2′deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene] on arylamine-DNA lesions in relation
to DNA replication and repair1, 2. In the present study, we present an unusual sequence
effect on a 16-mer fully paired DNA duplex 5′-CTTCTG1G2TCCTCATTC-3′, in which
the same lesion modification at G1 and G2 revealed a dramatic difference in S (basedisplaced stacked)/B (major groove binding B-type) conformational heterogeneity. We
obtained conformational (19F-NMR/CD), calorimetric (DSC and ITC), and binding
(SPR) data for a set of four 16-mer modified templates (FABP vs. FAF and TG 1*G2T
vs. TG1G2*T) during primer elongation. Dynamic 19F-NMR results indicate that FABP
modification at G1 and G2 resulted in 67%:33% of B:S and 100% B population ratios,
respectively, and the planar FAF in the same sequence contexts exhibited 25%:75% B:S
and 83%:17% B:S, respectively. A significant increase was observed in S-conformation
(0% to 17%) going from a twisted nonplanar FABP to a planar FAF. Calorimetric (DSC
and ITC) and UV-melting data revealed that the B-conformer is a thermodynamic
stabilizer in duplex settings, and the S-conformer is a destabilizer. The situation is
reversed during the primer elongation process that involves ss/ds duplexes, i.e., Sconformation promotes lesion stacking at the ss/ds replication fork. This finding is in
agreement with SPR binding results, which showed that lesion stacking increases the
binding affinity of the complementary strands in the order of FABP > FAF and G*GT
> GG*T. Surprisingly, our data revealed that the twisted biphenyl is a better stacker at
2

ss/ds junction than the coplanar FAF, possibly due to its ring flexibility that helps
accommodate the replication fork structures. This finding is not the case for fully paired
duplexes in which base-displaced stacking is enhanced by lesion planarity. The extent
of primer dissociation rates across the lesion was influenced by the DNA sequences and
the nature of the lesion (FAF vs. FABP). These results provide conformational insights
into the important role of ss/ds sequence effects in modulating bulky lesion-induced
translesion DNA synthesis.

3

INTRODUCTION
Abbreviation:

ABP:

N-(2′-deoxyguanosin-8-yl)-4-aminobiphenyl;

deoxyguanosin-8-yl)-2-aminofluorene;

AAF:

AF:

N-(2′-

N-(2′-deoxyguanosin-8-yl)-2-

acetylaminofluorene; 19FNMR: fluorine nuclear magnetic resonance.

When a replication polymerase encounters a DNA lesion, DNA synthesis pauses or
stops to allow the recruitment of bypass polymerases. This in turn will affect whether
the synthesis becomes error free or error prone. Some bulky DNA lesions at the singlestrand (ss)/double-strand (ds) replication fork can exist in multiple conformations,
which can affect mutational outcomes. In summary, a single bulky adduct can induce
conformational heterogeneity at the ss/ds replication fork, wherein a polymerase may
process each of the conformations in a uniquely different way. A similar conformational
argument can be made for DNA duplexes, which is the usual substrate for nucleotide
excision repair. The latter removes various bulky lesions, such as arylamines, aflatoxins,
and aristolochic acids.
Arylamines are carcinogens derived from cigarette smoke, incomplete combustion of
diesel exhaust, and overcooked meat among others 3, 4. These aromatic chemicals per se
do not directly interact with DNA; however, they are metabolized in vivo by cytochrome
P450 and subsequently activated by cellular enzymes, such as N-acetyltrasferase or
sulfotransferase to form DNA adducts5, 6. For example, the well-known human bladder
carcinogen 4-aminobiphenyl (ABP) is activated to produce C8-substituted dG-ABP as
a major DNA lesion7 8. The bulkier 2-aminofluorene (AF) and N-2-acetylaminofluorene
4

(AAF) produce similar C8-dG adducts (Figure 1a). These bulky DNA adducts have
been extensively studied and shown to adopt at least three major conformations in the
duplex setting: major groove B-type (B), base-displaced stacked (S), or minor groove
wedge (W) (Figure 1b), and the S/B/W-population ratios are influenced by neighboring
sequence contexts1,9, 10. In the S-conformation, the carcinogen stacks between the bases
and disrupts base pairing in the double helix, whereas the B-type conformer places the
carcinogen in the major groove of the DNA helix that maintains the traditional Watson–
Crick base pairings. The W conformer was originally found in dA mismatch duplexes,
and the hydrophobic lesion is well-placed in the narrow minor groove11–14. These
adducts exhibit sequence-dependent S/B/W population ratios and consequently have
different repair and mutational efficiencies1, 15, 16,12–14, 17. For example, the purine base
at the 3′-flanking base favors S-conformer in the AF- and AAF-modified duplexes 14, 17
12, 18–20

. AAF at G3 in the NarI sequence (5′-G1G2CG3CN-3′) induces a greater frequency

of −2 frame shift mutations with the G3-mutational frequency regulated by the nature of
the N base18,

21, 22

. Miller et al. reported a significant reduction in nucleotide

incorporation rates at neighboring and downstream of the lesion site by Klenow
fragment (Kf) exo–23. We investigated the sequence effect of AF on nucleotide insertion
efficiencies catalyzed by Kf–exo– on TG*A and CG*A translesion synthesis (TLS)
systems and found the S conformer of CG*A thermodynamically favors insertion of A
over C at the lesion site19.
We previously reported an unusual 3′-flanking T effect on a random duplex sequence
(5′-CCATCG*CNACC-3′; N=T or A), i.e., FABP modification at G exhibited a 40%:60%
B:S in the G*CT context whereas 100% B in the G*CA sequence context. Though not
5

as dramatic, a similar trend was observed for the AF and AAF lesions 1. In the present
paper, another unusual ABP-induced sequence effect on a random 16-mer duplex
sequence (5′-CTTCTG1G2TCCTCATTC-3′) was investigated. ABP-modification at G 1
exhibited a 67:33 ratio of B:S conformations, whereas the B conformation was adopted
exclusively at the G2 modification. We conducted a series of conformational [NMR,
induced circular dichroism (ICD)], thermodynamic [UV-melting, differential scanning
calorimetry (DSC)], and binding [surface plasmon resonance (SPR), isothermal titration
calorimetry (ITC)] experiments for two 16-mer ss/ds DNA templates [(5′CTTCTG1*G2TCCTCATTC-3′) and (5′-CTTCTG1G2*TCCTCATTC-3′); G1*/G2*
=FABP or FAF (fluorinated ABP, AF)], which mimic a TLS (Figure 2). The
experimental data showed that the B-conformer is a thermodynamic stabilizer and the
S-conformer is a destabilizer in full duplex settings. However, the opposite was true for
a simulated TLS that involved ss/ds sequences. Lesion stacking increased the binding
affinity of the complementary strands in the order of FABP > FAF and G*GT > GG*T.
The twisted nonplanar ABP was a better stacker than the planar AF in ss/ds systems,
which were in contrast to the duplexes. The present study provided valuable insights
into the important distinction between ss/ds and full ds sequence contexts and flanking
base sequences and lesion stacking in modulating bulky lesion-induced conformational
heterogeneity.

MATERIALS AND METHODS
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Caution: 4-Aminobiphenyl derivatives are known human bladder carcinogens.
Aminofluorene analogues are animal carcinogens; therefore, must be handled with
caution.

Oligodeoxynucleotides (oligo, 10 µmol scale) in desalted form were obtained from
Integrated DNA Technologies (Iowa) and were purified by using a reverse phase HPLC.
The HPLC system comprised a Hitachi EZChrom Elite HPLC with a L-2450 diode array
detector and a Phenomenex Luna C18 column (150 x 10 mm, 5.0 µm) (Phenomenex,
Torrance, CA). All HPLC solvents were purchased from Fisher Inc. (Pittsburgh, PA).

Preparation of Lesion-Modified Oligodeoxynucleotides
FABP-modified 16-mer templates (5′-CTTCTG 1G2TCCTCATTC-3′) were prepared
according to the published procedures22. For each lesion, we obtained two monoadducts [d(5′-CTTCTG1*G2TCCTCATTC-3′)] and [d(5′-CTTCTG1G2*TCCTCATTC3′)] (G*=FABP) and one di-adduct [d(5′-CTTCTG 1*G2*TCCTCATTC-3′)]. Briefly, 5–
10 mg of N-acetoxy-N-trifuoroacetyl-7-fluoro-4-aminobiphenyl dissolved in 500 µL
absolute ethanol was added to 10 mL sodium citrate buffer (10 mM, pH 6.0) containing
approximately 200 ods of unmodified 16-mer oligo and incubated in a 37 °C water bath
shaker for 1 h. Unreacted carcinogens were removed by extraction with anhydrous ether.
An acetonitrile gradient of 14%–25% in triethylammonium acetate (TEAA) buffer (100
mM, pH 7.0) for 30 min was used to separate the two mono-adduct strands from diadduct and unreacted 16-mer oligos. Figure 3 shows the HPLC profile and photodiode
array UV spectra of FABP-modified 16-mers. The combined collection of the two
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mono-adduct oligos was lyophilized and stored in −80°C. FAF-modified 16-mer oligos
were prepared similarly according to published procedures and the resulting HPLC
profile is shown in Figure 4.

MALDI-TOF Mass Spectrometry Characterization of Mono-adducts
The FABP- and FAF-modified mono-adducted 16-mer oligos above were digested by
3′–5′ exonuclease enzyme digestion and characterized by MALDI-TOF mass
spectrometry following published procedures24. Briefly, 1 µL (0.1 unit) of snake venom
phosphodiesterase (SVP) was added to a solution of 1 µL of modified oligo (~100–200
pmol), 6 µL of ammonium citrate (100 mM, pH 9.4), and 6 µL of water for 3′–
5′digestion. In each case, 1 µL of the reaction mixture was withdrawn at regular time
intervals and was quenched by mixing with 1 µL of matrix (3-hydroxypicolinic acid and
diammonium hydrogen citrate in a 1:1 ratio). All MALDI spectra were obtained using
Shimadzu Axima Performance MALDI-TOF mass spectrometer equipped with a 70 Hz
nitrogen laser in positive ion reflectron mode12.

UV Melting
UV thermal melting experiments were performed on a Cary100 Bio UV-Vis
spectrophotometer (Santa Clara, CA) equipped with a 6 × 6 multi-cell chamber (1.0 cm
path length) and connected with a built-in Peltier temperature controller. Samples were
prepared in the buffer (containing 0.2M NaCl, 10 mM sodium phosphate and 0.2 mM
EDTA at pH 7.0) in the range of 0.8 µM to 5.6 µM. Samples were scanned
forward/reverse five times during melting experiments. Thermodynamic parameters
8

were calculated using the program MELTWIN version 3.5 according to previous
reports22.

DSC
DSC calorimetry measurements were performed on a Nano-DSC from TA Instrument
(Lindon, UT, USA) according to previous reports25. Solutions at 0.1 mM containing
unmodified or modified templates with various primers were dissolved in a pH 7.0
buffer (0.1 M NaCl, 20 mM sodium phosphate), and the solutions were incubated at
95 °C for 5 mins and cooled at room temperature for 3 h to ensure duplex formation.
After 15 min degassing, samples were loaded into the instrument cells. A buffer scan
was used as control and then subtracted from the sample scan and normalized for heating
rate. All samples were scanned against the control buffer from 15 °C to 85 °C at a rate
of 1 °C/min by measuring five repetitions. Raw data were collected as microwatts versus
temperature. ΔH is an integration of ΔCpex over temperature T. Tm was the temperature
at half the peak area. Thermodynamic parameters (ΔG and ΔS) were determined
according to previously described procedures26, 27.

CD Spectra
Circular dichroism (CD) experiments were conducted on a Jasco J-810
spectropolarimeter (Easton, MD) equipped with a Peltier temperature controller.
Typically, a modified template (20 µM) was annealed with an equimolar amount of a
primer in 400 µL buffer (containing 0.2M NaCl, 10 mM sodium phosphate, and 0.2 mM
EDTA, pH 7.0). The samples were hybridized by heating to 95 °C for 5 min and slowly
9

cooled to room temperature for 3 h to ensure duplex formation. Spectra were acquired
every 0.2 nm from 200 nm to 400 nm at a rate of 50 nm/min for five repetitions and
smoothed with 25-point adaptive algorithms provided by Jasco 14.

Dynamic 19F -NMR
Approximately 0.1 mM of full and ss/ds duplex samples (Figure 2) were dissolved in
250 µL of NMR buffer (pH 7.0) containing 10% D2O/90% H2O, 100 mM NaCl, 10
mM sodium phosphate, and 100 µM EDTA. Solutions were filtered into a Shigemi tube
through a 0.22 µm membrane filter. All 1H and 19F NMR experiments were performed
on a Varian NMR spectrometer with a HFC probe operating at 500.0 and 476.5 MHz,
respectively9, 16, 28. Imino proton spectra was obtained at different temperature points
(5 °C to 50 °C) using phase-sensitive jump-return sequences and referenced to DSS.
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F-NMR spectra were recorded with increment of 5 °C–10 °C (from 5 °C to 60 °C) in

the 1H-decoupled mode and referenced to C6F6 in C6D6 at −164.9 ppm. Computer line
shape simulations were processed as reported previously using MestReNova 10.0.2
(Mestrelab Research, Spain)9, 29.

SPR
SPR binding measurements were conducted using a Biacore T200 instrument (GE
Healthcare, Marlborough, MA). Two isomeric 16-mer biotinylated DNA template
strands

(5′-biotin-CTTCTG1*G2TCCTCATTC-3′

and

5′-biotin-

CTTCTG1G2*TCCTCATTC-3′; G*= FABP or FAF) were each modified with FABP
or FAF2, 20, 25, 30. HPLC gradient conditions for biotinylated FABP-modified oligos were
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16%–25% gradient on acetonitrile for 55 min in TEAA buffer (100 mM, pH 7.0) with
a flow rate of 3.0 mL/min (Figure 5a). The biotin-FABP-modified sequences were
characterized by MALDI-TOF-MS using 3–5′exonuclease enzyme digestion (Figure
5b–c).

Carboxymethylated CM 5 chip was activated by amine coupling kit according to
published procedures20, 25, 30. Streptavidin (SA, 50 µg/mL dissolved in sodium acetate
buffer, pH 4.5) was coated on flow cells 2, 3, and 4 after the injection of EDC/NHS
mixture for 7 min. Flow cell 1 was left as blank. Ethanolamine (1 M) was injected over
the surface to block unreacted esters. The unbound SA was removed by five pulses of
50 mM NaOH and three pulses of running buffer. The surface was stabilized for 20–30
min in running buffer before DNA coating. Flow cells 2, 3, and 4 were coated around
300 RU of unmodified DNA sequence (–G1G2T–), FABP modified (–G1*G2T–) and (–
G1G2*T–) DNA sequences by the manual control mode, respectively. Samples of 9- to
16-mer primer sequence were prepared separately in HBS-P+ buffer (10 mM Hepes,
150 mM NaCl, 0.05% surfactant P20 at pH 7.4) and injected over the chip surface with
100 s contact time and 360 s dissociation time at a flow rate of 15 µL/min at 25 °C.

Due to distinct molecule weights, the primers (9- to 16-mer) were used at different
concentrations to gain steady-state associations: 300 nM (9-mer), 500 nM (10-mer), 500
nM (11-mer), and 750 nM (12-, 13-, and 16mer). After the system reached a steady state,
excess primers were washed off by the HBS-P+ buffer, and the system was regenerated
by adding NaOH (50 nM, 30 s). We were unable to measure the usual KD (kd/ka) kinetics
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of duplex formation for each elongation. Instead, we used dissociation rates (kd), which
are concentration-independent, to estimate binding strengths for complementary strands.

Dissociation constants (kd) were analyzed in kd-alone fitting mode by Scrubber software
(version 2.0, Myszka and collaborators, BioLogic Software). The goodness of the fit
was determined from the residual standard deviation.

ITC
VP-ITC microcalorimeter from MicroCal Inc. (Northampton, MA) was performed to
measure full duplex formation of unmodified and modified templates (2.5 µM) with
their complementary (25 µM) sequences prepared in 10 mM phosphate buffer (pH 7.0),
containing 0.2 M NaCl and 0.2 mM EDTA. The samples were degassed thoroughly
under vacuum using ThermoVac (MicroCal, Northampton, MA) for 20 mins. ITC
experiments consisted of 25 consecutive injections and each injection involves 10 µL
of complementary sequence with injection time 10 s and 240 s intervals between each
injection with 307 rpm stirring at 25 °C. The integrated and normalized areas of raw
data were plotted as ΔH of injectant against the molar ratio. The titration data were fitted
using a single-site binding model provided in ORIGIN7.0 software supplied by the
manufacturer. ΔH, ΔS, K, and N (reaction stoichiometry) of 16-mer full duplex
formation were obtained31, 32.

Modeling Dynamic Simulation
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The initial undamaged helix (5′-CTTCTG1G2TCCTCATTC-3′) was generated using the
NAB module of AMBER 1433. The helix was modified to position the FABP-dG adduct
at G1 or G2 such that the lesion was paired opposite dC. At each position, three
orientations of the lesion site were considered to generate the B, S, and W adducted
DNA conformations. Resulting duplexes were neutralized with Na+ ions and solvated
in a TIP3P octahedral water box with sides 8.0 Å from the solute. All natural nucleotides
were modeled with the AMBER ff14SB force field34, 35. FABP-dG parameters were
assigned according to the GAFF36 and AMBER ff14SB force fields using
ANTECHAMBER 1.4 (Table 1)37, and partial charges were developed using RESP
charge fitting from a HF/6-31G(d) calculation by using R.E.D.v.III.4 program (Table
1)38.
Each system was initially minimized with a 500 kcal/mol Å2 constraint on the DNA for
500 steps of steepest descent and 500 steps of conjugate gradient minimization.
Subsequently, 1,000 steps of unrestrained steepest descent and 1,500 steps of
unrestrained conjugate gradient minimization were performed on the entire system.
Each system was then heated over 20 ps at constant volume to 300 K. Heating was
performed using a Langevin thermostat (γ = 1.0) and a 10 kcal/mol Å2 constraint on the
DNA. Subsequently, each system was simulated for 100 ns at 300 K using a 2 fs time
step. To prevent unnatural unravelling of the DNA helices throughout the MD
simulations, a 25 kcal/mol Å2 harmonic distance restraint was used to maintain the
heavy atom–heavy atom distance in the Watson–Crick hydrogen bonds for the terminal
G:C base pairs between 2.0 Å and 4.0 Å. During simulations, the SHAKE algorithm
was used to constrain covalent bonds involving hydrogen, and the periodic boundary
13

condition was applied. The particle mesh Ewald algorithm was used for long-range
electrostatic interactions, with a nonbonded cutoff of 8.0 Å. All simulations and analysis
were completed with Amber 14 using the pmemd and cpptraj modules, respectively33.

RESULTS
Experimental DNA Sequences. Chemical structures of ABP and AF and their fluorine
analogues, FABP and FAF, are shown in Figure 1a. We previously observed that FABPmodified 12-mer DNA duplex 5′-CTTCTG1G2TCCTC-3′ at G1 and G2 resulted in
60%:40% of B:S and 100% B population ratios, respectively. In the present study, the
original 12-mer was extended to 16-mer (5′-CTTCTG1G2TCCTCATTC-3′) by adding
“–ATTC–” to the 3’-end to improve thermal stability for the n − 1 and n TLS duplexes.
NMR results indicate that the fully paired FABP modified 16-mer duplexes exhibited
67%:33% of B:S and 100% B population ratios for G 1 and G2 modifications, which are
in good agreement with those observed above for the original FABP-modified 12-mer
duplex.

As shown in Figure 2, the two 16-mer template strands (TG 1*G2T- or TG1G2*T-: G* =
FABP or FAF) were each annealed with various lengths of complementary strands (9to 16-mer) to generate two discrete model TLS systems (n − 2, n − 1, n, n + 1, n + 2, n
+ 5 for -G1*G2T- and n − 1, n, n + 1, n + 2, n + 3, n + 6 for -G1G2*T-, respectively; n is
the lesion site). In the present study, we used these TLS model systems consistently for
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F-NMR/CD, DSC, UV melting, and SPR experiments. Our strategy is to investigate

the effects of the S/B conformational heterogeneity on thermodynamic and duplex
14

binding parameters. The results will help us understand the uniqueness of flanking base
sequence in the TGGT context in promoting lesion-induced conformational
heterogeneity.

MALDI-TOF Characterization. FABP- and FAF-modified 16-mer oligos were
characterized by exonuclease enzyme digestion followed by MALDI-TOF mass
spectrometry, according to published procedures12,

24, 25

. Figure 6a–b shows the

MALDI-TOF MS spectra of the 3′-5′ SVP exonuclease digestions of peaks 1 and 2 from
FABP-HPLC profile at different time points (0, 0.5, 2, and 5 min). Briefly, the m/z of
4,958 at 0 min represents the control mass to charge ratio of the modified template
without SVP. Within 0.5 min of 3′-5′ exonuclease digestion (Figure 6a), the lower
masses showed up corresponding to the 15-mer to 6-mer fragments. The fragment at
m/z = 1,943 (theoretical 1945), which was the most detectable mass between 2 min to
5 min digestion, was assigned to a 6-mer containing the FABP lesion. These results
confirmed that peak 1 from the HPLC profile was the G1*-FABP-modified sequence
(5′-CTTCTG1[FABP] G2TCCTCATTC-3′, G1*G2T). Peak 2 from HPLC profile was
characterized similarly. Figure 6b shows the control molecular ion m/z of 4,961 at 0
min. The m/z 2272 ion peak in the 0.5–5 min of digestion corresponded to the 7-mer
fragment containing FABP-modified guanine. These results confirm peak 2 as the G2*FABP modified sequence (5′-CTTCTG1G2[FABP] TCCTCATTC-3′, G1G2*T).

The FAF-modified 16-mer templates have been characterized similarly. Figure 7a–b
shows the MALDI-TOF MS spectra of the 3′–5′ SVP exonuclease digestion of the FAF-
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modified 16-mer oligo (peaks 1 and 2) at different time intervals. The m/z of 4972
(theoretical 4971) in peak 1 at 0 min (before digestion, as a control) indicated the 16mer
DNA sequence containing a FAF-modified DNA base. From 0 min to 3 min, with the
disappearance of the original oligonucleotide (4972) the digestion process has been
observed when new lower masses showed up corresponding to the smaller fragments
from 3′ cleavage (e.g., 4682, 4377, and 4073). After digestion for 3 min, the digestion
stopped at m/z = 1955 (theoretical 1955), which represented the FAF-modified 6-mer
fragment and confirmed peak 1 as G1*-FAF modified sequence (5′-CTTCTG1[FAF]
G2TCCTCATTC-3′, G1*G2T). Following the same procedure, we found the SVP
digestion of peak 2 stalled at m/z = 2284 (theoretical 2284) after 3 min and confirmed
peak 2 as G2*-FAF modified sequence (5′-CTTCTG1G2[FAF] TCCTCATTC-3′,
G1G2*T). Taken together, the SVP enzymatic digestion from the 3′-end is slowed down
significantly at lesion sites of 6- and 7-mer representing G1*G2T and G1G2*T,
respectively.

Dynamic 19F-NMR Spectroscopy
Dynamic
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F-NMR experiments were performed to measure the extent of

conformational heterogeneity during primer elongation. Figures 8 and 9 show the
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F-

NMR spectra of the FABP- and FAF-modified duplex series as function of temperature
(5 °C–60 °C). The same sequence systems were used for CD, DSC, UV-melting, and
SPR experiments for comparison. Briefly, FABP-G1*-16-mer duplex showed a mixture
of S (33%) and B (67%) conformations at 25 °C (highlighted in Figure 8a). By contrast,
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the corresponding FABP-G2*-duplex exclusively revealed B-conformer (100%) with
no sign of conformational heterogeneity.

FABP-G1*G2T
In Figure 8a, no indication of conformational heterogeneity at n − 2 (9-mer) and n − 1
(10-mer) was found, whereas the 3′-end of the primer did not reach the lesion site. A
slight heterogeneity was observed at n (11-mer); however, but interestingly it
disappeared at n + 1. At n + 2 (16/13-mer), however, we observed complex 19F signals
indicating the presence of multiple conformations. These 19F signals were coalesced into
a sharp single peak around −116 ppm upon around and above 50 °C; this result indicates
duplex melting. The conformational pattern was steadied at fully paired 16-mer duplex
(n + 5), which showed a ratio of 33% S and 67% B populations at 25 °C (highlighted in
Figure 8a).

The
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F-signals were assigned according to the general protocols based on relative

chemical shifts, chemical exchange patterns, and H/D isotope effects 2. We have
investigated a number of 19F-NMR spectra of arylamine-modified duplexes in various
sequence settings and found that the fluorine of the S-type conformer resonates always
upfield relative to that of the external binding B-type conformer and they are in slow
exchange and eventually coalesce into a denatured ss. In addition, the 19F tag in the Bconformation is fully exposed to the solvent in the major groove area, whereas that of
the S-conformer is shielded from van der Waals interactions with neighboring base pairs.
In addition, the fully exposed 19F tag of the major groove binding B-conformer always
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exhibits significant deuterium isotope effect (0.18 ppm) going from 10% to 100% D 2O
(Figure 10 a–b). This result is in contrast to the buried
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F of the stacked conformer,

which shows no isotope effect (0.08 ppm) (Figure 10 a).

FABP-G1G2*T
G2-modfied series shown in Figure 8b is quite different from the G 1-modified above.
Some minor heterogeneities are observed on n − 1 (16/9-mer) and n + 3 (16/12-mer); in
general, all duplex sequences exhibited one major signal around −117.5 ppm. This
signal can be assigned as the B-like conformer because of its close proximity to the
coalescent signal (ss) and also by comparison with the G 1 modified duplex above.

FAF-G1*G2T and FAF-G1G2*T
Figure 9a–b show the dynamic
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F-NMR spectra for the FAF-modified series. The

results indicate both FAF-G1*G2T and FAF-G1G2*T duplexes adopted more S
conformation than the FABP series. FAF-G1*G2T had approximately 42% more S− than
the FABP counterpart G1*G2T (75% S & 25% B) in the full duplex, whereas the S−
increased from 0% to 17% in the FAF/G1G2*T. These results reflected the planar nature
of FAF relative to FABP preferring to intercalate/stack. Moreover, the B-conformer
exhibit significant deuterium isotope effect (~ 0.18 ppm) going from 10% to 100% D 2O
whereas the stacked conformer shows little isotope effect (0.04 ppm) (Figure 11a–b).

ICD
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Figure 12 shows CD overlays of unmodified and FABP-modified 16-mer templates with
increasing primer length. The S curve consisted of +@270 nm, and the B-form DNA
duplex consisted of −@250 nm. Given the conformational heterogeneity, FABPmodified TLS duplexes exhibited lesion ICD between 290 nm and 360 nm 17, 22. This
result is in contrast to the unmodified control series, which showed no such ICD. The
ICD gradually increases along with the primer elongation from 9-mer to 16-mer. In the
fully paired 16-mer duplex, T agrees with the above

19

F-NMR data, which showed a

B/S-conformeric TG1*G2T and exclusively B-conformeric G1G2*T on fully paired 16mer duplexes. The predominant B-conformer of G1G2*T highly affects the bending of
DNA helix around the adduct site. G1 and G2 FABP-modified duplexes displayed slight
blue shifts (~3 nm) relative to the unmodified controls, indicating adduct-induced DNA
bending24. Similar results were obtained for FAF-modified series (Figure 13).

UV Melting Experiments
The UV-melting profiles of all the ss/ds duplex models were measured at the 0.8−4.0
µM range for FABP and FAF samples. The UV monophasic and sigmoidal melting
curves between lnCt and Tm−1 (R2 > 0.9) confirmed that the duplexes adopted a typical
helix-coil transitions.9 Figure 14a–b shows the plots of melting (Tm) for modified
duplexes as a function of primer elongation for TLS systems.

Figure 14a–b shows the melting results of FABP and FAF lesions at the G 1*G2T (red)
and G1G2*T (yellow) systems (red dash lines and yellow dash lines, respectively)
relative to the unmodified controls (blue solid lines). Thermal and thermodynamic
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parameters calculated from UV melting curves are summarized in Tables 2 and 3. For
all the modified and unmodified duplexes, Tm increases with the elongation of primers.
However, modified systems showed stalls around the lesion sites.

Lesion effect in the G1*G2T system was minimal at one and two bases before the lesion
sites (ΔTm of 0.35 °C and 0.67 °C for 9-mer and 10-mer, respectively). This finding is
in contrast to that of the G1G2*T system, which showed minimal lesion effect at those
sites (9-mer ΔTm of 1.45 °C). However, the effect was significant when the primer
elongation was opposite the lesion [11-mer and 10-mer for G 1*G2T (ΔTm= -2.54 °C)
and G1G2*T (ΔTm= -5.21 °C), respectively]. In full duplex (16-mer), G1*G2T showed
greater negative thermodynamic effect to G1G2*T (ΔTm of −7.68 °C to −6.29 °C), which
can be due to the S-conformer (see19F NMR results above).

DSC
DSC experiments were performed for the FABP-modified TLS models (TLS/TG 1*G2T
vs. TLS/TG1G2*T). Figure 15a–d shows DSC thermogram overlays of excess heat
capacity Cpex vs. temperature. Tm is the maximum point of the curves, and transition
enthalpy (ΔH) is the area under the curves. DSC results are superior to UV-melting due
to its independent concentration, thereby providing reliable thermodynamic parameters.
DSC results are summarized in Table 425, 39.

Control TLS
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Figure 15a shows the DSC thermograms for the control TLS system. For the natural
DNA, Tm and ΔH values increased progressively with increasing primer length from 9mer (Tm = 42.9 °C, ΔH = −71.4 kcal/mol) to 13 mer (Tm = 59.8 °C, ΔH = -87.2 kcal/mol)
and increased significantly at full duplex (16 mer, Tm = 63.1 °C, ΔH = −98.5 kcal/mol).

G1[FABP]G2T Duplex
In FABP-G1 profiles (Figure 15b), the 9-mer primer, which is two bases (n − 2) before
the lesion (n), showed a minimal lesion effect, i.e., Tm 43.3 °C is compared with the
control duplex 42.9 °C. However, 10-mer (n − 1) to 16-mer (n + 5) primers were stalled,
i.e., their Tm values were clustered between 51 °C and 53 °C. The 16-mer full duplex
showed a significant increase in enthalpy ΔH, indicating a full duplex formation.

G1G2[FABP]T Duplex
DSC patterns for the TG1G2*T system (Figure 15c) were similar to those of the
TG1*G2T. Curves for 10-(n) to 13-( n + 3) mer were clustered between Tm 45 °C and
53 °C, which is lower than that of the TG1*G2T counterpart. The increase in ΔH was
not as incremental as that of Tm. In general, the exclusively B-conformeric 16-mer
TG1G2*T full duplex showed greater Tm and ΔH than the G1 counterpart that contains a
mixture of B and S conformers (see
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F-NMR above). This finding suggests that B-

conformation can be a thermodynamic destabilizer during primer elongation and yet Sconformer might produce thermodynamic destabilization in full duplex. TG1*G2T and
TG1G2*T duplexes in TLS settings show consistently smaller Tm and ΔH compared with
the unmodified controls (Figure 15d).
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ITC for Duplex Formation
ITC is a direct solution technique and provides the nature of duplex formation through
a sigmoidal curve and the respective thermodynamic parameters (ΔH, ΔG, ΔS) through
plots of heat capacity (Cp) vs. molar ratios. This result indicates that the lesion
destabilizes the duplex formation.

Figure 16 shows ITC thermograms of duplex formation for FABP and FAF-modified
GGT sequences at 25 °C. In all cases, unmodified controls (black) showed well-defined
sigmoidal curves with sharp changes in heat capacity at starting and ending points. The
results indicate a typical cooperative 1:1 binding process (e.g., molar ratio of N = ~1)
expected for formation of Watson–Crick-based DNA duplexes. By contrast, the ITC
curves for modified full duplexes were not well defined in terms of stoichiometry and
overall shape, probably due to heterogeneity. Table 5 summarizes the ITC-derived
thermodynamic parameters ΔH, ΔS, K, and N for unmodified and modified sequences,
for example, the binding constant order is GGT (49.9 M−1) > G1*G2T (18.7 M−1) >
G1G2*T (5.9 M−1) in FABP case. In general, the ΔH and the binding constant of the
modified sequences are consistently lower than that of the controls, and the FABP shows
more variances in shapes than the FAF counterpart.

SPR on Duplex Formation
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SPR experiments were conducted to probe the effect of conformational heterogeneity
on duplex formation and dissociation. The results were obtained in buffer-only
environment without a polymerase. With different concentrations used for each
complementary strand, we measured dissociation rates (kd) to evaluate their binding
strengths (see Results).

Figure 17 shows the entirety of SPR results, and Table 6 lists the respective dissociation
rate constants. Figure 18 shows the overlay of sensograms for FABP and FAF lesions
on the unmodified (green) and the G1 (blue)/G2 (purple) sequences with increasing
length of complementary strands. As expected, in each complementary sequence, SPR
data show gradual reduction in kd values with elongation in unmodified and modified
sequences.

By contrast, rapid duplex formation took place for all duplexes; different dissociation
rates were observed for modified duplexes. In general, slower dissociation indicates
greater duplex binding with thermodynamic stability. This appears to be generally true
with post-lesion duplexes (16/11- to 16/16-mer). The 16/9-mer duplexes, which
represents the prelesion n − 2 and n − 1 site for G1 and G2, respectively, showed
generally faster dissociation (Figure 19a, Table 6): G1G2[FABP]T (7.1 s−1) <
G1[FABP]G2T (12 s−1) < unmodified (16.5 s−1). As for the 16/10-mer (Figure 19b),
however, dissociation was dramatically slower for G1*G2T (0.343 s−1) than the
unmodified (0.515 s−1) and G1G2*T (2.37 s−1). These results are consistent with duplex
stability in the order of TG1*G2T > unmodified > TG1G2*T. The 16/9-mer is one base
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before (n − 1) the G1G2*T, and 10/16mer is one base (n − 1) before the G1*G2T duplex.
The results suggest that the modified n − 1 duplexes may form a stable S-conformer at
the ss/ds junction, resulting in slow dissociation. Similar SPR patterns were observed
for the FAF lesion (Figure 18b); however, general dissociation rates were slightly faster
compared to the FABP lesion. This finding indicates that FABP is a better stacker in the
ss/ds duplex setting.

Modeling Dynamic Simulation
With increasing size, we can pinpoint the effects of different components of the system
by using a variety of different models.
FABP-dG Nucleoside: The first model we considered was the nucleoside model. The
FABP-dG nucleoside has greater conformational flexibility in the syn-conformation (Sconformer) compared to the anti-conformation (B-conformation). The bulky moiety
prefers a twisted conformation about the linkage between the two rings (Figure 20).
FABP-dG DNA Duplex: Figure 21 shows that the DNA helix is more stable with FABP
positioned at G2 compared with that at G1. B conformation is preferred at G1 and G2
positions. At G1, the W conformation is also stable because of interactions with the 5′
backbone. Steric prevents such an interaction at G2. The FABP adduct does not affect
the structure of the flanking base pairs.
ss/ds DNA Junction: ss/ds DNA junction is difficult to model because of the flexibility
of ssDNA. Greater conformational flexibility is observed with FABP-dG is positioned
at G1. Similar to the DNA model, intercalation of the bulky moiety does not increase
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the stacking energetics. However, energies were hard to compare due to the variation in
structure of the ssDNA.
Summary: Twisted conformation of the bulky moiety destabilizes the S conformation.
In general, the B conformation is most stable regardless of model or stand sequence.
Formation of a stable W conformation is dictated by the flanking bases. Flanking bases
affect the conformation adopted by FABP-dG.

DISCUSSION
Unusual Flanking Sequence Effects on the TG1G2T Sequence
In this study, we present a striking flanking sequence effect on a 16-mer fully paired
DNA duplex 5′-CTTCTG1G2TCCTCATTC-3′, in which lesion modification at G1
(TG1*G2T sequence) and G2 (TG1G2*T sequence) yielded a dramatic difference in
conformational heterogeneity. Dynamic
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FNMR results indicate that FABP

modification at G1 and G2 resulted in 67%:33% of B:S and 100% B population ratios,
respectively. Modification with the planar FAF in the same sequence contexts exhibited
greater S-conformer population: 25%:75% B:S and 83:17% B:S for the G 1 and G2
position, respectively. This represents a significant increase in S-conformation from 33%
to 75% and from 0% to 17% going from FABP to FAF on the G 1*G2T and G1G2*T
sequence context, respectively.

This example is analogous to our recent reporting on a random 11-mer DNA duplex
sequences 5′-CCATCG*CNACC-3′ (N = T or A), in which FABP modification
exhibited a 40%:60% ratio of B:S and 100% B and FAF modification resulted in 10%:90%
25

and 34%:66% in the G*CT and G*CA sequence context, respectively1, 2. These 3′-next
flanking sequence effects influence primer kinetics, DNA replication, and repair. Lesion
stacking was primarily responsible for the greater population of the stacked S-conformer
compared with that of G*CA counterparts; the S conformation decreased the binding
affinity

of

complementary

strands.

These

adduct-induced

conformational

heterogeneities are caused by 3′-next flanking sequence effect, which is different from
the G1G2T in the present study, which represents the flanking sequence effects.

Our calorimetric results showed a greater thermodynamic stability for the Bconformeric G2 over the S/B-conformeric G1 in the full duplex, which indicates that the
B-conformer is a thermodynamic stabilizer in fully paired duplex DNA. This finding is
consistent with our modeling data, which show that DNA duplex is more stable with
FABP positioned at G2 compared with G1, and B-conformer is preferred at G1 and G2
positions. The greater S-conformer population of FAF over FABP at duplex DNA is
probably due to their aromatic coplanarity, i.e., the single-carbon atom methylene
bridging between two aromatic rings in FAF restricts the twisting of the biphenyl and
enhances the stacking capability. As shown in ITC curves (Figure 16), lesion
modification has reduced enthalpic energies (~13% and ~17% average for FABP- and
FAF-G1/G2, respectively) during duplex formation, as expected. The lesion destabilizes
the duplex formation. Correlating the ITC data with conformation heterogeneity is
difficult; hence, the difference in ring planarity had a major effect on the shape of
binding isotherms (C), i.e., FABP has greater sequence differences compared with FAF.
Modeling data also indicate that the low-energy S conformation at G 1 and G2 is not

26

much different; however, a unique low-energy W-conformer at G 1 position is observed
due to the interactions with the 5′ backbone. By contrast, steric clash prevents such an
interaction at G2. These results may explain the sequence-dependent isotherm
fluctuation in the G1 over G2.

Thermodynamic Effect on Lesion Heterogeneity during Primer Elongation
We studied six discrete TLS model duplexes prepared by annealing the 16-mer
TG1*G2T and TG1G2*T (G* = FABP or FAF; Figure 2) modified template with
appropriate primer strands. These experiments were performed in buffer solutions
without a polymerase. The main objective of these experiments is to study the effect of
the lesion-induced S/B-heterogeneity on their thermal and thermodynamic stabilities
during the primer elongation that mimics a TLS.

The thermodynamic results show a systemic increase in Tm and ΔH with primer
elongation from 9-mer to 16-mer in unmodified control duplexes. However, FABP
modification has generally lowered Tm and ΔH, as well as changed their calorimetric
curve patterns for G1*G2T and G1G2*T systems. As mentioned above, for full duplexes,
the exclusively B-conformeric G2* was more thermally stable than G1*. However, this
fining is not observed during the primer elongation from 10-mer to 13-mer, in which
average Tms of G1G2*T is lower that of the G1*G2T. These results imply that the Bconformer is a thermodynamic stabilizer in the duplex setting but is a destabilizer during
primer elongation. In other words, S-conformer may play as a thermodynamic stabilizer
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in the TLS (as presented below), although modeling data indicate that the intercalation
of the bulky moiety does not increase the stacking energetics.

The Impact of Lesion Heterogeneity on ss/ds Duplex Formation
We performed SPR experiments to investigate the effect of lesion heterogeneity on
strand binding that simulates a TLS. SPR is an excellent real-time technique that allows
monitoring for formation and dissociation of DNA duplexes, DNA–RNA hybridization,
and triplex formation. Figure 18 shows an overlay of SPR sensorgrams as a function of
various complementary strands (9-mer to 16-mer). Sensorgrams from SPR for each
primer elongation and dissociation rate kd (Table 6) was used to evaluate lesion and
sequence effects. This finding is due to the different concentrations of each primer
elongation; thus, conducting a global binding analysis is difficult for KD affinity values
(see Results). Instead, we utilize kd dissociation rates (Table 6) to examine lesion effects.

The binding strength for each primer elongation was increased with increasing extent
of Watson–Crick hydrogen bonds. As a result, dissociation rates are steadily reduced
with primer elongation. Not surprisingly, binding strength for the unmodified templates
was generally greater than that of the modified ones throughout the TLS process.
Initially, the effect was relatively minimal at prelesion sites (n − 1 and n − 2 for G1* and
G2*, respectively) (Figure 19a, 9-mer). According to NMR results, the FABP-G 1* lesion
with the 9-mer (16/9-mer) is likely to exist in a B/S-mixture that can be readily
accommodated in the flexible n − 2 environment. As for G2*, this represents n − 1, in
which the mostly B-conformer can exist at the 16-/9-mer ss/ds junction. Small, modified
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16/9-mer sequences appeared to be slightly more stabilized than the controls. However,
the effect of lesion modification on dissociation was clearly seen around the lesion sites.
The 16/10-mer corresponds to n − 1 and n for G1* and G2*, respectively. The effect on
dissociation was in the order of n − 1 G1* > control > n G2*. The most significant lesion
effect of G1* at n − 1 is probably due to the presence of S-conformer population that
can stabilize the ss/ds replication fork (see above). This situation is illustrated in Figure
19b. For G2*, the primer has advanced up to the lesion site (n); hence, such lesioninduced stacking cannot attain the same stability. Modeling an ss/ds sequence was
difficult and indicated a greater flexibility of the FABP lesion at G1*; however, this
sequence does not support stacking-induced stabilization at the replication fork. As a
result, n G2* was less stable than that of the unmodified control. The opposite was true
for the 16/11-mer, in which the binding stability at G1* was reduced at the lesion site
presumably due to the clash with the new primer. This is not the case for the Bconformeric G2* at n + 1, which did not change much other than the usual gain of
binding energy through elongation. The trend remained unchanged for the rest of the
elongation (n + 2, +3) and for the full (n + 16) duplex.

As shown in Figure 18, the nature of the lesion (FABP vs. FAF) had no noticeable effect
on dissociation rates, except that FAF dissociates generally faster than FABP (Table 6).
A similar situation was noted in our previous GCA/GCT examples 2. Although no
polymerase

was

involved,

these

SPR

results

are

in

line

with

the

NMR/thermodynamic/modeling results given that the greater S-conformation of the G 1*
sequence posed a major hindrance toward the binding affinity. In other words, the lesion
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effect was propagated primarily upstream of the template strand and gradually
diminished.

SUMMARY
We conducted systematic 19F NMR, CD, DSC, and SPR studies for the elongation of
the TG1*G2T and TG1G2*T sequences modified by FABP and FAF. Model systems
mimic a hypothetical TLS process involving the bulky structurally related arylamine
lesions. DNA adducts in the TG1*G2T duplex exhibited greater populations of the Sconformer compared with that in the TG1G2*T duplex. Bulky lesions exhibited unique
sequence-dependent conformational heterogeneities at various elongation positions,
including the replication fork that differentially contributes to template-primer bindings
and thermodynamics. We found that the B-conformer is a major thermodynamic
stabilizer in the duplex settings and the S-conformer is a destabilizer. The opposite was
observed during the primer elongation process involving ss/ds duplex sequences, i.e.,
the S-conformation promotes lesion stacking with nascent base pairs at the ss/ds
replication fork. The results are supported by SPR sensograms, which revealed that the
bulky adduct in the stacked conformation increases the binding affinity of the
complementary strands in the order of FABP > FAF and G1*G2T > G1G2*T.
Interestingly, unlike the coplanar FAF, the twisted FABP is a better stacker at ss/ds
junction than in fully paired duplexes. The extent of primer dissociation rates across the
lesion were influenced by the flanking DNA sequences and the stacking ability of the
lesion. Future studies include examination of the effects of the conformational
heterogeneity in DNA replication and repair.
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FIGURE LEGENDS
Figure 1. (a) Structures of ABP [N-(2ˈ-deoxyguanosin-8-yl)-4-aminobiphenyl], AF [N(2ˈ-deoxyguanosin-8-yl)-2-aminofluorene], and AAF [N-(2ˈ-deoxyguanosin-8-yl)-2acetylaminofluorene] and their fluoro models, FABP [N-(2ˈ-deoxyguanosin-8-yl)-4’fluoro-4-aminobiphenyl], FAF [N-(2ˈ-deoxyguanosin-8-yl)-7-fluoro-2-aminofluorene],
and FAAF [N-(2ˈ-deoxyguanosin-8-yl)-7-fluoro-2-acetylaminofluorene]. (b) Major
groove views of arylamine-conformational motifs: B-, S-, and W-conformers. (color
code: Arylamine- red CPK, modified dG- blue, complementary C- orange).
Figure 2. Translesion synthesis (TLS) models for (a) unmodified control, (b)
FABP/FAF-modified G1 (G*GT) templates, and (c) FABP/FAF-modified G2(GG*T)
templates.
Figure 3. HPLC chromatogram of a reaction mixture of 16-mer sequence (5'CTTCTG1G2TCCTCATTC-3')

with

an

activated

FABP

(N-Acetoxy-N-

(trifluoroacetyl)-4’-fluoro-4-aminobiphenyl) and photodiode array UV spectra of
unmodified, mono-, di-FABP adducts.
Figure 4. HPLC chromatogram of a reaction mixture of 16-mer sequence (5'CTTCTG1G2TCCTCATTC-3') with an activated FAF (N-acetoxy-N-(trifluoroacetyl)7-fluoro-2-aminofluorene) and photodiode array UV spectra of unmodified and monoFAF adducts.
Figure 5. HPLC profile, photodiode array UV spectra of mono-FABP adducts and
MALDI-TOF mass spectra of FABP modified biotinylated 16mer-GGT for SPR
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experiments: (a) HPLC chromatogram of FABP modified biotinylated 16mer-GGT. (b)
3’-enzyme digestion of peak 1 at 0min, 0.5min, 3min 5min, 6min and 7min. (c) 3’enzyme digestion of peak 2 at 0min, 0.5min, 3min 5min, 6min and 7min. Insets show
the theoretical MW of the corresponding fragments that should form after 3’-enzyme
digestion.

Figure 6. MALDI-TOF mass spectra of FABP modified 16mer-GGT: (a) 3’-enzyme
digestion of peak 1 at 0min, 0.5min, 2min and 5min. (b) 3’-enzyme digestion of peak
2 at 0min, 0.5min, 2min and 5min. Insets show the theoretical MW of the corresponding
fragments that should form after 3’-enzyme digestion.
Figure 7. MALDI-TOF mass spectra of FAF modified 16mer-GGT: (a) 3’-enzyme
digestion of peak 1 at 0min, 0.5min, 1min, 2min, 3min, 5min and 6min. (b) 3’-enzyme
digestion of peak 2 at 0min, 0.5min, 1min, 2min, 3min, 5min and 6min. Insets show the
theoretical MW of the corresponding fragments that should form after 3’-enzyme
digestion.
Figure 8. Dynamic 19F-NMR spectra (5-60°C) of FABP-modified duplexes with primer
elongation. (a) FABP-modified G1 (G*GT) showing a 67% B- and 33% Sconformational mixture in full duplex. (b) FABP-modified G2 (GG*T) exhibiting 100%
B-conformer in full duplex. For all of the duplexes, the

19

F signals around 60°C

coalesced into a sharp single peak around -115ppm indicating a denatured FABPresidue. * indicates unassigned minor conformers.
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Figure 9. Dynamic 19F-NMR spectra (5-60°C) of FAF-modified duplexes with primer
elongation. (a) FAF-modified G1 (G*GT) showing a 25% B- and 75% Sconformational mixture in full duplex. (b) FAF-modified G2 (GG*T) exhibiting 83%
B- and 17% S-conformer in full duplex. For all of the duplexes, the 19F signals around
60°C coalesced into a sharp single peak around -117ppm indicating a denatured FAFresidue. * indicates unassigned minor conformers.
Figure 10. Deuterium isotope effect of FABP-modified 16-mer GGT full duplexes in
10% and 100% D2O at 25°C. (a) FABP-modified G1 (G*GT) (0.18 and 0.08 ppm for
B- and S-conformer, respectively). (b) FABP-modified G2 (GG*T) (0.18 ppm for Bconformer).
ΔδS= |δS (100% D2O) - δS (10% D2O)|; ΔδB= |δB (100% D2O) – δB (10% D2O)|.
Figure 11. Deuterium isotope effect of FAF-modified 16-mer GGT full duplexes in 10%
and 100% D2O at 25°C. (a) FAF-modified G1 (G*GT) (0.19 and 0.04 ppm for B- and
S-conformer, respectively). (b) FAF-modified G2 (GG*T) (0.18 and 0.04 ppm for Band S-conformer, respectively).
ΔδS= |δS (100% D2O) - δS (10% D2O)|; ΔδB= |δB (100% D2O) – δB (10% D2O)|.
Figure 12. CD spectral overlays of primer elongation (9 mer to 16 mer) for FABP
modified 16-mer GGT at 25°C. (a) unmodified control, (b) FABP modified G1 (G*GT),
(c) FABP modified G2 (GG*T), (d) Full duplex overlays of unmodified and FABP
G1/G2-modified sequences.
Figure 13. CD spectral overlays of primer elongation (9 mer to 16 mer) for FAF
modified 16-mer GGT at 25°C. (a) unmodified control, (b) FAF modified G1 (G*GT),
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(c) FAF modified G2 (GG*T), (d) Full duplex overlays of unmodified and FAF G1/G2modified sequences.
Figure 14. (a) UV melting (Tm) of FABP modified 16-mer GGT with primer elongation
(9 mer to 16 mer). (b) UV melting (Tm) of FAF modified 16-mer GGT with primer
elongation (9 mer to 16 mer). Unmodified control is blue line, FABP/FAF-modified G1
(G*GT) is shown as red dash line, and FABP/FAF-modified G2 (GG*T) is shown as
yellow dash line.
Figure 15. DSC heat capacity ΔCp vs temperature (15-85 °C) for primer elongation (9
mer to 16 mer) of the (a) control, (b) FABP modified G1 (G*GT) and (c) FABP
modified G2 (GG*T). (d) Full duplex overlays of unmodified and FABP G1/G2modified sequences. FABP-G1 and FABP-G2 show smaller Tm and ΔH than the
control/unmodified in full duplex exhibiting that S-conformer (FABP-G1, G*GT) might
produce thermodynamic destabilization in full duplex.
Figure 16. ITC binding thermograms of duplex formation for (a) FABP- and (b) FAFmodified 16 mer GGT full duplexes at 25°C.
Figure 17. SPR sensorgrams of unmodified and FABP/FAF-modified TLS: (a)
Unmodified and FABP-modified G1 (G*GT) and G2 (GG*T), (b) Unmodified and
FAF-modified G1 (G*GT) and G2 (GG*T).
Figure 18. Normalized SPR sensorgrams of (a) FABP- and (b) FAF- modified 16 mer
GGT sequences with primer elongation (9 mer to 16 mer). Slower dissociation shows
better stability of the primer−template duplexes.
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Figure 19. Normalized SPR sensorgrams of FABP-modified 16 mer GGT sequences
with 9-mer and 10-mer primers, and progression of lesion conformational rigidity. (a)
9-mer and (b) 10-mer. Slower dissociation shows better stability of the primer−template
duplexes.
Figure 20. syn- and anti-FABP-modified dG and their energy barrier from nucleoside
MD (Modeling Dynamic) simulation.
Figure 21. FABP-dG DNA helices structures from MD simulation. (a) G 1 position, (b)
G2 position. B conformation is preferred at both the G1 and G2 positions.
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TABLE LEGENDS
Table 1. Partial charges and atom types for FABP-dG.
Table 2: UV melting thermal and thermodynamic parameters of FABP modified 16mer G1 (G*GT) and G2 (GG*T) duplexes.
Table 3: UV melting thermal and thermodynamic parameters of FAF modified 16-mer
G1 (G*GT) and G2 (GG*T) duplexes.
Table 4. Thermal and Thermodynamic Parameters Derived from DSC.
Table 5. Thermodynamic parameters C, N, K, ΔH and ΔS derived from the ITC.
Table 6. Dissociation off-rate constants (kd, x10-2, s-1) from SPR.
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Table 1:
Atom Name
P
O5'
OP1
OP2
O3'
C5'
H5'1
H5'2
C4'
H4'
O4'
C1'
H1'
C3'
H3'
C2'
H2'1
H2'2
N9
C8
N7
C5
C6
O6
N1
H1
C2
N2
H21
H22
N3
C4
N8
H8
C9
C10
H10
C11
H11
C12
H12
C13
H13
C14
C15
C16
H16
C17
H17
C18
H18
C19
H19
C20
F

Atom Type
P
OS
O2
O2
OS
CT
H1
H1
CT
H1
OS
CT
H2
CT
H1
CT
HC
HC
N*
CK
NB
CB
C
O
NA
H
CA
N2
H
H
NC
CB
N2
H
CA
CA
HA
CA
HA
CA
HA
CA
HA
cp
cp
CA
HA
CA
HA
CA
HA
CA
HA
CA
F
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Charge
1.1625
-0.4931
-0.7634
-0.7699
-0.5407
-0.0122
0.0791
0.0791
0.1579
0.1088
-0.403
0.1931
0.0679
0.1358
0.0758
-0.057
0.0457
0.0457
-0.0447
0.5148
-0.5657
0.1146
0.5093
-0.5442
-0.4523
0.3452
0.6267
-0.8744
0.3894
0.3894
-0.5033
0.1036
-0.6715
0.3746
0.369
-0.1778
0.1531
-0.3158
0.1754
-0.1902
0.1513
-0.1284
0.1387
0.0446
0.0704
-0.0807
0.1214
-0.4271
0.1965
-0.2676
0.1899
0.4444
-0.101
-0.1481
-0.0416

Table 2:
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Table 3:
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ABSTRACT
Bulky organic carcinogens are usually activated in vivo and form DNA adducts. Some
of these DNA adducts exist in multiple conformations that are slowly interconverted to
one another. For example, the dG-C8-lesion of the human bladder carcinogen 4aminobiphenyl (ABP) has been reported to exist in a sequence-dependent mixture of
B/S conformations. Different conformations have been shown to lead to different
kinetic capacities, binding capacities, and ultimately different translesion synthesis and
transcription capacities. Although rare, conformation-dependent mutagenic and repair
patterns have been reported. For example, the bulky N-acetylaminofluorene at G 3 in the
NarI sequence (5′-G1G2CG3CN-3′) induces a high frequency of −2 frameshift mutations,
whereas the adducts on G1 and G2 are not mutagenic. Results show why mutagenic
hotspots exist in the genome. However, the conformation-specific replication block,
which is more relevant to replication, has not been reported. Such research deficiency
may be due to the dynamicity of the replication block process. As such, the replication
block becomes difficult to capture by current end-point assays, which usually detect
either the ensemble of consequence of all the conformers or the culmination of all
cellular behaviors, such as mutagenicity or survival rate. In Manuscript I, we showed
very unusual sequence-dependent conformational heterogeneities involving FABPmodified DNA under different sequence contexts (TG1*G2T [67%B:33%S] and
TG1G2*T

[100%B],

G*,

FABP,

N-(2′-deoxyguanosin-8-yl)-4′-fluoro-4-

aminobiphenyl). Different biological consequences are believed to be linked to different
adducts. In the present study, we attempted to correlate the replication block to different
conformations from the single FABP-modified DNA lesion. We utilized a combination
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of biophysical (SPR and steady-state kinetics) tools to reveal the differences in vitro.
The results were discussed in terms of conformational differences.

73

INTRODUCTION
The human genome is under constant assault from the environment. DNA-damageinduced mutations are known to trigger chemical carcinogenesis 1-2. Therefore,
understanding the mechanisms of DNA mutations is important. Arylamines belong to a
notorious group of environmental mutagens/carcinogens that produce bulky DNA
adducts in vivo3. These lesions have been well documented to adopt the following three
unique conformational motifs: the major groove B-type (B), stacked (S), or minor
groove wedge (W). As such, the lesions complicate mutational and repair outcomes
(Figure 1a)4.

4-Aminobiphenyl (ABP) is a well-known human bladder carcinogen that forms
preferentially dG-C8-substituted adducts (dG-C8-ABP) (Figure 1b)5-7. Our structural
studies (Manuscript I) showed that fully paired duplexes containing dG-C8-FABP
(fluorine-labeled ABP, FABP, N-(2′-deoxyguanosin-8-yl)-4′-fluoro-4-aminobiphenyl)
adopted a 67%:33% mixture of the B- and S-conformers in the TG 1*G2T (G*=FABP)
sequence context at 25 °C. Meanwhile, the same lesion in the TG1G2*T context
exhibited exclusively the B-type conformation under identical experimental conditions.
When a replication polymerase encounters a bulky DNA lesion, the polymerase likely
stalls or completely stops DNA synthesis. In this case, the lesion influences whether the
DNA replication will be error free or error prone. The aforementioned striking sequence
effect warrants systematic polymerase binding studies. Vaidyanathan et al. 8 probed into
the sequence effect of dG-C8-AF, the ABP analog, on nucleotide insertion efficiencies
catalyzed by the Klenow fragment (Kf-exo−) on TG*A and CG*A sequences. The
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researchers found that the S conformer of CG*A thermodynamically favors the insertion
of A over C at the lesion site. Xu et al.9 reported that Kf-exo− is a strong binder to
template/primer junctions, but with minimal nucleotide selectivity against modified
DNA. The sequence-dependent conformational heterogeneity may play an important
role in DNA replication and mutation. In the present study, we hypothesize that different
conformations lead to different extents of polymerase binding affinities, kinetics, and
replication blocks, ultimately resulting in complex mutational outcomes. We also
conducted SPR and steady-state enzyme kinetics in vitro to probe into the effect of ABPinduced conformational heterogeneity.

MATERIALS AND METHODS
Model Oligonucleotide DNA sequences.
FABP-modified 16-mer templates (5′-CTTCTG1G2TCCTCATTC-3′) were prepared in
accordance

with

the

published

procedures10:

CTTCTG1*G2TCCTCATTC-3′))

(G*=FABP)

CTTCTG1G2*TCCTCATTC-3′))

(G2*

two

(G1*

adduct).

mono-adducts
adduct)

and

5′-biotin-labeled

(d(5′(d(5′31-mer

oligonucleotides, 5′-phosphorylated and 3′-dideoxy-A 53-mer, 5′-phosphorylated and
3′-dideoxy-C 54-mer were purchased from IDT (Integrated DNA Technologies, Inc.
Coralville, IA) in desalted form and purified by reverse-phase high-performance liquid
chromatography (RP-HPLC). Kf-exo− (D355A, E357A) was purchased from NEB Inc.
(Ipswich, MA). All high-performance liquid chromatography (HPLC) solvents were
purchased from Fisher Inc. (Pittsburgh, PA). The modified oligonucleotides were
purified by HPLC (Thermo Scientific, Madison, WI) on a Phenomenex Luna C18
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analytical column (100 × 46 mm, 3.0 μm) (Phenomenex, Torrance, CA). For the FABPmodified biotinylated 31-mer sequences, a 0.2 mL/min flow rate was used in a 48 min
linear gradient profile (2% to 26%, v/v) acetonitrile with 100 mM TEAA buffer (pH 7.0)
in a mobile phase (Figure 2a).

HPLC-based Steady-State Kinetic Analysis
The extension efficiency of Kf-exo− polymerase opposite G1* and G2* adducts were
determined by steady-state kinetic experiments as described by published reports 11-14.
All reactions were performed using Kf-exo − (100 nM) and primers (5 µM) in NEB
buffer 2 (New England Biolabs, MA) at 22 °C. The primers (8-mer to 12-mer) were preannealed with 6.75 µM FABP-modified or unmodified 16-mer templates by heating up
to 70 °C and slowly cooling down to room temperature. Five different concentrations
of dCTP or dATP (0, 12.5, 25, 50, and 100 µM) were used to initialize nucleotide
insertion. All reactions were quenched by adding ethylene diamine tetraacetic acid
followed by immediately denaturing at 80 °C. The initial velocity of each reaction
within the steady-state range was then obtained by performing every reaction within a
short time period from 5 s to 30 s. The extended and unextended primers were separated
by anion-exchange HPLC at 40%–60% B, 6.5 min gradient conditions (A: water and B:
1.5 M ammonium acetate) and quantified by absorbance of UV at 260 nm. All reactions
were performed at 22 °C in triplicate, and the results were analyzed through the
GraphPad Prism 5 software by using the Lineweaver–Burke model. The inhibition
curves were fitted to the equation 1/V = 1/Vmax + (KM/Vmax)/[SdCTP]. The relative
insertion efficiency fins was obtained as (kcat /KM)modified/(kcat /KM)unmodified.
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SPR Measurements
FABP-modified Hairpin Template/Primer Constructs. 5′-Biotinylated 31-mer
containing dG-C8-FABP in the “-TG1G2T-” sequence context was used in SPR analysis
following the reported procedures9, 15-16. The two FABP-modified biotinylated 31-mer
G1* and G2* adducts were separated by RP-HPLC and characterized by MALDI-TOF
mass spectrometry (MS)17. An 84-mer and an 85-mer hairpin–template–primer were
prepared by following the reported protocols18. Briefly, two different lengths of hairpin
DNA sequences (53- and 54-mer) were prepared. These two hairpin sequences were
phosphorylated at their 5′-terminals, but their 3′-terminals were modified with ddA and
ddC, respectively, to prevent further primer elongation (Figure 3a). The biotinylated 31mer modified G1* adduct and 54-mer hairpin were desalted by G-25 spin columns and
annealed together by heating to 95 °C for 5 min and cooling to room temperature. The
mixture solution was ligated in a buffer containing 4,000 units of T4 ligase enzyme for
16 h at room temperature. The resulting 85-mer oligonucleotides were purified in 15%
denaturing polyacrylamide gel and extracted using the electroelution method followed
by desalting by again using G-25 spin columns. The pure biotinylated 85-mer was
finally purified by RP-HPLC. G2* adduct biotinylated 84-mer and unmodified
biotinylated 84- and 85-mers were also prepared similarly. All the 84- and 85-mer
oligonucleotides were identified by the 15% denaturing polyacrylamide gel (Figure 4).

Immobilization of Streptavidin (SA) on CM5 S Chip and DNA Coating
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SPR experiments were carried out using Biacore T200 (GE Healthcare, Piscataway, NJ).
The SA via the amine coupling kit was immobilized on flow cells on the
carboxymethylated dextran-coated CM5 S chip by following the reported procedures 9,
16

. After SA immobilization at around 2,000 RU on the flow cells, the chip surface was

washed with 50 mM NaOH for 60 s five times to reach below 20 RU. Then, the running
buffer was injected around three times, and the system was equilibrated with running
buffer for ~2 h. The 84- and 85-mer unmodified and modified G 1* and G2* biotinylated
DNA sequences (2 nM) were injected over the flow cells (2 to 4) for 90-120 s to achieve
5-6 RU. The surface was stabilized with running buffer for 3 h before conducting SPR
binding affinity experiments.

Real-time Kinetic Analysis
Initially, the SPR system was primed at least three times with running buffer and zeroconcentration injections to condition the plasmon surface. The DNA was coated on the
SA surface of flow cells 2 to 4 (cell 1 as blank reference). Surface testing, regeneration
buffer scouting, and mass transport limitation test were conducted prior to kinetics
experiments following previous reports9, 16. DNA coating around 4-5 RU did not show
any impact of mass transport. The steady-state affinity analysis of Kf-exo − binding to
unmodified and modified DNA was analyzed in the absence (binary) and presence of
dNTPs (ternary) by varying Kf-exo− concentrations.

For the binary system, Kf-exo− was injected without dNTPs over the DNA surface in
varying concentrations (0-25 nM) and repeated twice as described by previous reports 9.
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Briefly, the 1× HBS-P running buffer (containing 100 μg/mL bovine serum albumin
[BSA] and 5 mM MgCl2) with six different concentrations Kf-exo− (0-25 nM) was
injected for 30 s at a flow rate of 100 μL/min over the cells. Afterward 0.05% SDS was
applied as regeneration solution at a flow rate of 100 μL/min over the surface for 30 s.
The surface was stabilized with running buffer for 15 min after a regeneration step
between different concentration circles.

For the ternary system, dNTPs were injected with the HBS-P running buffer for
comparison. 1× HBS-P running buffer (100 μg/mL BSA, 5 mM MgCl 2, and 100 μM
individual dNTPs) with varying concentrations of Kf-exo− was injected over the surface.
For both binary and ternary systems, sensorgrams were fitted by using a 1:1 Langmuir
model, and the binding affinity constants (KD) were determined using steady-state
affinity analysis in the BIA evaluation software v 1.0.

RESULTS
Model Systems
For SPR binding experiments, we constructed two biotinylated hairpin-based template–
primer strands (Figure 3a), 85-mer G1* adduct and 84-mer G2* adduct (G* = FABP).
Specifically, two FABP-modified–biotin–31-mer DNA sequences (TG 1*G2T and
TG1G2*T) were separated, purified, and characterized individually by enzyme
digestion/MALDI-MS9 (see below). The 54-mer hairpin DNA was annealed and ligated
to the biotin–31-mer TG1*G2T oligonucleotide, whereas the 53-mer hairpin DNA was
ligated to the biotin–31-mer TG1G2*T oligonucleotide. The hairpin structures were used
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to improve the stability of the oligonucleotide during SPR experiments and the lesion
G1* and G2* adduct were at the 21st and 22nd bases, respectively, to avoid clash
between the polymerase protein and the gold chip surface9.

For steady-state kinetics experiments, two 16-mer G1* or G2* template strands were
each annealed to various lengths of complementary strands (8-mer to 11-mer) to create
n-3, n-2, n-1, and n for the G1* adduct and n-2, n-1, n, and n+1 for G2* (n is the lesion
site) (see Manuscript I).

MALDI-TOF Characterization
The FABP-modified biotin–31-mer oligos were characterized by exonuclease enzyme
digestion followed by MALDI-TOF MS in accordance with the published procedures 9,
17

. In the present case, 5′-3′ exonuclease digestion was not possible because of the biotin

group present at the 5′ end of the DNA. Figure 2b shows the MALDI-TOF MS spectra
of the 3′-5′ snake venom phosphodiesterase (SVP) exonuclease digestions of the biotin–
31-mer G1* adduct at different time points (0, 1, 4, 6, 7, 8, and 10 min). The m/z of
9,804 (theoretical 9,803) at 0 min represents the control mass-to-charge ratio. Within 6
min of 3′-5′ exonuclease digestion, the lower masses appeared corresponding to the 27mer to 21-mer fragments. The m/z = 6,788 (theoretical 6,787) fragment, which persisted
in 6 min to 10 min was assigned to the G1*-FABP-modified 21-mer. These results
confirmed the first eluting peak (peak 1) from the HPLC profile (Figure 2b) as the
biotin–31-mer TG1*G2T. Figure 2c presents the MALDI-TOF MS spectra of the HPLC
peak 2 with 3′-5′ exonuclease digestions. The digestions were fast in the first 4 min
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showing the m/z range from 9,803 to 7,116. However, the reaction stalled at m/z 7,116
from 4-10 min corresponding to the 22-mer fragment containing the FABP-modified
guanine (theoretical m/z = 7,116). These results confirm peak 2 as the G 2*-FABPmodified biotin–31-mer sequence.

The 84- and 85-mer biotinylated oligonucleotides were purified and identified by 15%
denaturing polyacrylamide gel (Hercules, CA). Figure 4 reveals the denaturing gel
profiles of unmodified/modified 84- and 85-mer ligated oligonucleotides, biotin–31mer, and 53-mer/54-mer non-ligated oligonucleotides. For the 85-mer control, all the
biotin–31-mer and 54-mer hairpins were ligated. As for the 84-mer control, 85-mer G 1*,
and 84-mer G2*, excessive biotin–31-mer, 54-mer, and 53-mer were observed. The
ligated 85-mer control/ G1* and 84-mer control/ G2* were employed for SPR
experiments.

HPLC-based Steady-state Kinetics
We conducted steady-state experiments to investigate the impact of conformational
heterogeneity on nucleotide insertion kinetics19. The E. coli exonuclease-deficient Kfexo− was used for single-nucleotide incorporation, and the results are summarized in
Table 1. dATP was added to 16/8-mer and 16/11-mer systems, whereas dCTP was
added to 16/9-mer and 16/10-mer sequences.

dCTP: Specifically, adding dCTP to the n-1 (16/9-mer) G2* adduct elongated the
oligomer to 10- and 11-mer, whereas the n-1 (16/10-mer) G 1* adduct produced a single
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11-mer. The 10- and 11-mer mixture from the G2* adduct sequence was difficult to
quantify; thus, reduction of the starting 9-mer was employed to determine the kinetics
analysis.

The n-1 (16/9-mer) G2* adduct showed a Km value (5.7 µM) similar to that of the control
(5.8 µM); such similarity indicates equal affinity (Table 1). However, the insertion
efficiency fins of dCTP opposite -G2* was 5-fold lower than that of the unmodified
control (0.24 :1) (Table 1). By contrast, the Km of the G1* adduct showed a lower affinity
(23.4 µM) than that of the control (7.4 µM). The insertion efficiency fins in G1* was three
times lower than the control (0.33 to 1). As shown by the Lineweaver–Burke enzyme
inhibition model (Figure 5a), the (16/10-mer) G 1* adduct and its control intersected on
the Y-axis. A competitive inhibition behavior was indicated. By contrast, the n-1 16/9mer G2* adduct and its control merged at the x-axis. This behavior can only be explained
as non-competitive inhibition (Figure 5b). When the n-1 (16/9-mer) G 2* adduct
elongated to 10-mer (n) and 11-mer (n+1), few 10-mer primers but most of the 11-mer
primers were observed. This result was achieved because the bulky FABP on the G 2 at
the lesion site (n) did not block the replication from n-1 to n+1.

dATP: The conformational and long-range lesion effect was examined by initiating the
primer elongation with a 16/8-mer template/primer that produces n-2 for G 2* and n-3
for G1*. Figure 6a presents the results at 10 min. In the control, ~70% of the 8-mer was
extended to 9-mer. With adduct on G1, ~40% of the 8-mer was converted to 9-mer. This
result is a moderate pre-lesion effect at G1*. However, G2* blocked ~80% of the 8-mer
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converting to 9-mer; this effect indicates a much stronger pre-lesion effect than that of
G1* This result is not surprising because the 8-mer primer is closer to the G 2* adduct
than the G1* adduct. In the 11-mer (Figure 6b), unmodified control exhibited 90% of
dATP insertion efficiency. However, only ~20% of the 11-mer was elongated to 12-mer
opposite the G1* lesion. This finding indicates a strong post-lesion effect. Moreover,
only ~55% of the 11-mer was converted to 12-mer in the n+1 G2*. These results suggest
the significant retardation of insertion rates close to the lesion site.

Kf-exo− SPR binding Kinetics
Binary System—Figure 3b shows the sensorgrams for the binary binding between Kfexo− and unmodified controls (85-mer/84-mer TGGT) or modified sequences (85-mer
TG1*G2T/84-mer TG1G2*T). These sequences represent a true replication fork for the
G1* and G2*, respectively. Kf-exo− showed a much stronger binding to the modified 85mer TG1*G2T and 84-mer TG1G2*T sequences than to their unmodified controls (85mer/84-mer TGGT), respectively (Table 2). Specifically, the binding affinity (KD) of
Kf-exo− in the 85- and 84-mer was reduced by 8.3- and 5.6-fold, respectively, for the
G1* and G2* adducts related to the controls. The differences were more striking in the
dissociation rates (85-mer TGGT kd: 0.84 s−1 vs. 85-mer TG1*G2T kd: 0.17 s−1; 84-mer
TGGT kd: 0.03 s−1 vs. 84-mer TG1G2*T kd: 0.009 s−1). The Kd ratio (Kd-modified/Kdcontrol) between G1 and G2 was (20%:30%) showing 1.5 times difference (Figure 3c).
In contrast to Kd, the Ka ratios of G1 and G2 were close to each other. This closeness
indicates similar association rates. The net stabilization energies for the binary system
were positive (Table 3). Although only one base length (dC) differed between the 84-
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mer and 85-mer, the binding affinity of the unmodified 84-mer was 18.2-fold tighter
than that of the 85-mer. Similarly, the KD of the 84-mer TG1G2*T was 12.2-fold greater
than that of the 85-mer TG1*G2T.

Ternary System— Kf-exo− bound tightly to the unmodified controls when the correct
dCTP was introduced in the ternary system (Figure 7). In the unmodified 85-mer, the
binding affinities of dATP and dGTP were exceedingly weak to be measured, and the
KD for the dTTP was reduced by 234-fold relative to the correct dCTP. The binding
affinities of the dATP, dGTP, and dTTP to the 84-mer controls were reduced by 315,
284, and 89 fold, respectively, relative to that of the dCTP (Table 2). However,
nucleotide selectivity was extremely low for the modified ternary complexes. The KD
value for the 85-mer TG1*G2T was only reduced by ~5-fold in the dATP, dGTP, and
dTTP than that of dCTP. Similar results were obtained for the 84-mer G 2* adduct, where
binding tightness was reduced by ~2-fold in the dATP, dGTP, and dTTP compared with
that of dCTP. Moreover, as in the binary system, slower dissociation rates were
observed for the unmodified and G2* modified 84-mers. The KD values of dCTP, dATP,
dGTP, and dTTP in the unmodified and G2* modified 84-mers were smaller than those
of the unmodified 85-mer (5- and 13-fold smaller in dCTP and dTTP) and G 1* modified
85-mer TG1*G2T (4-, 13-, 10-, and 12-fold smaller in dCTP, dATP, dGTP, and dTTP,
respectively).

DISCUSSION
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In Manuscript I, we conducted systematic 19F-NMR, CD, DSC, and SPR studies for the
elongation of the 16-mer G1*G2T and G1G2*T (G*=FABP) template sequences. These
model systems mimic a TLS process involving the bulky FABP lesion in two different
conformational states, that is, G1 and G2 modification resulted in 67%:33% of B:S and
100% B population ratios, respectively. These sequence-dependent conformational
complexities appeared to persist at various elongation positions, including the
replication fork. The B-conformer is a major thermodynamic stabilizer in duplex
settings, whereas the S-conformer is a destabilizer. The opposite was the case for ss/ds
duplex sequences. In particular, the S-conformation promotes lesion stacking with
nascent base pairs at the replication fork. SPR results reveal that the S-conformation
increased the binding affinity with the complementary strands in the order of G 1* > G2*.
In the present work, we examined the effects of these unusual sequence effects on
polymerase binding (binary and ternary) and nucleotide insertion kinetics.

Improvement in Model Hairpin Oligonucleotide Construction
We previously reported a construction of biotinylated hairpin-based template–primer
strand for DNA–polymerase SPR binding studies.9, 15-16 The general strategy is to ligate
a biotinylated arylamine-modified 31-mer sequence with 52-mer hairpin DNA to form
an 83-mer hairpin, followed by adding a ddNTP to the 3′-end to prevent primer
elongation. However, ddNTP addition is low yielding, and the separation of ligated
products is difficult. In the current study, successfully directly ligated a biotinylated
modified 31-mer with ddNTP-containing 53- and 54-mer hairpin DNA. This process
improved the yield (from ~10% to ~ 30%), and the products were readily separated.
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Previously, individual dNTPs (100 μM) were mixed with varying concentrations of Kfexo– in sample buffer and injected over the surface without any dNTP in the running
buffer. In this experiment, two variables were involved, that is, dNTPs and Kf–exo –16.
However, in the updated buffer system, each dNTP was prepared in running buffer.
Thus, only one variable, Kf–exo–, was introduced onto the chip surface. This change
increased the system stability and accuracy in simulating a TLS system.

Lesion and Sequence Effects on Binding Affinities and Kinetics
Tight binding of Kf–exo– with native unmodified dG was observed when the correct
nucleotide dCTP was presented in both 85-mer and 84-mer. This result strongly agreed
with our expectation that showed high nucleotide selectivity (KD dCTP ≪ KD dTTP < KD
dATP

~ KD dGTP). Meanwhile, an exceptionally tighter binding of Kf–exo – was found for

the FABP-modified sample relative to the control, i.e., the KD of the 85-mer G1* and
84-mer G2* interactions were 8.3 and 5.6 fold higher than the corresponding native
controls, respectively. Adduct-induced tighter binding affinity with Kf–exo– has been
reported9, 20 and may be due to the interactions between the bulky FABP and the nearby
hydrophobic amino-acid residues in the active site of the Kf-exo –. In the ternary system,
nucleotide selectivity was low. In particular, the KD of the dCTP at the opposite G1* and
G2* was only ~5- and ~2-fold tighter than the incorrect dATP, dGTP, and dTTP,
respectively. This result is a strong lesion effect. We observed that the usual 1:1 model
fittings did not achieve a clean fit of dCTP for G1* in the ternary system. This result
might be due to the S/B conformational heterogeneity observed at G 1*. Our steady-state
kinetics results indicated the S/B-conformeric G1* was involved in competitive
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inhibition. In other words, the S/B conformation at G1* was not as accommodating
possibly because of some unfavorable interaction of the bulky FABP lesion with the
incoming dCTP in a competitive manner. The unfavorable interactions may be caused
by the competition of S-conformer with dCTP opposite of the guanine. However, the
B-conformeric G2* accommodated an incoming nucleotide, and this situation resulted
in non-competitive inhibition. The equal affinity (Km) between G2* and its control
revealed that the B-conformation in the major grove may not affect the dCTP insertion
process. This finding might explain the greater KD of dCTP at G1* over G2* and
indicated a weaker binding affinity. As another possibility, the B-conformer did not
interfere with the Watson–Crick (W–C) base pair, but the adduct in the B-conformation
may have altered the native conformations or retarded the formation of phosphate
diester bond. G2* operated as a non-competitive inhibitor. Meanwhile, G 1* is a B- and
S-conformeric mixture. The S-conformer cannot provide a perfect W–C base pair for
regulation and replication. The S-conformation may need to convert back to the Bconformation to be replicated. Thus, the S-conformer may function as a competitive
inhibitor for replication and block the replication. We observed a competitive-inhibition
model for G1* but a non-competitive-inhibition model for G2*. These types of
intermediate interactions may be a requisite step in the DNA polymerase proofreading
mechanism.

SUMMARY
We carried out SPR and steady-state kinetics in vitro studies for the replication block
with different conformations. In Manuscript I, the FABP-modified DNA achieved a
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mixture of B and S conformations in the TG1*G2T (67%B:33%S) and exclusively B in
the TG1G2*T sequence context. In our present work, as indicated by the Lineweaver–
Burke enzyme inhibition model, the (16/10-mer) G1* adduct exhibited a competitiveinhibition behavior, whereas the G2* adduct served as a non-competitive inhibitor in the
nucleotide insertion kinetics. These results revealed that the S-conformer may not have
accommodated incoming dCTPs and exhibited a competitive behavior with incoming
nucleotides and blocked the replication. By contrast, the B-conformer did not interfere
with the W–C base pairing nor ultimately affected the dCTP insertion. As such, the Bconformer showed non-competitive-inhibition behavior. The SPR findings also
implicated an adduct-induced tightened binding affinity with Kf-exo – in a binary system
that is consistent with our previous reports. Moreover, in a ternary system, nucleotide
selectivity diminished when FABP modified G1 and G2. We observed the effect of bulky
lesion-induced replication fork conformational heterogeneity. Future studies would
include the bypass replication in bacterial and in mammalian cell systems.
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FIGURE LEGENDS
Figure 1. (a) The views of FABP-conformational motifs: B-, and S-conformers. ABPred, modified dG-blue, complementary C-orange. (b) dG-C8-FABP.
Figure 2. (a) HPLC chromatogram of a reaction mixture of biotinylated-31-mer
sequence

(5'-Bio-CCTCTTCCCTCACCTCTTCTG1G2TCCTCATTC-3')

activated

FABP

with

(N-Acetoxy-N-(trifluoroacetyl)-4’-fluoro-4-aminobiphenyl)

an
and

photodiode array UV spectra of unmodified, mono-adducts. (b) MALDI-TOF mass
spectra of FABP modified biotinylated-31mer-TGGT: (a) 3’-enzyme digestion of peak
1 at 0, 1, 4, 6, 7, 8 and 10min. (b) 3’-enzyme digestion of peak 2 at 0, 1, 4, 6, 7, 8 and
10min. Insets show the theoretical MW of the corresponding fragments that should form
after 3’-enzyme digestion.
Figure 3. (a) Hairpin template−primer oligonucleotide constructs of 85-mer G1 and 84mer G2 for Kf-exo−; (b) Sensorgrams of binary complexes of Kf-exo− with 85-mer and
84-mer unmodified control, G1-FABP and G2-FABP modified sequences (1:1 binding
fitted curves are overlaid as black lines); (c) Ka (Ka-modified / Ka-contol) and Kd (Kdmodified / Kd-contol) ratio, G1 and G2 represent the ratio of 85-mer FABP-G1/85-mercontrol and 84-mer FABP-G2/84-mer-control, respectively.
Figure 4. Denaturing gel (15%) profiles of 84-mer and 85-mer ligated oligonucleotides,
31-mer, 53-mer and 54-mer non-ligated oligonucleotides.
Figure 5. Lineweaver – Burk model of the DNA Repair Reactions Catalyzed by the Kfexo− at (a) 10-mer, G1-FABP and (b) 9-mer G2-FABP lesion sites with dCTP at steady91

state. According to the model, the behavior of G1-FABP against with Kf–exo– showed
as a competitive inhibitor, whereas the behavior of TG1G2*T played as non-competitive.
Figure 6. dATP insertion efficiency results of (a) 8-mer to 9-mer and (b) 11-mer to 12mer in control, G1*G2T-FABP and G1G2*T-FABP, respectively, in 10 min.
Figure 7. Sensorgrams of ternary Kf-exo− complexed with (a) 85-mer control, (b) 85mer TG1[FABP]G2T, (c) 84-mer control and (d) 84-mer TG1G2[FABP]T sequences in
the presence of dNTPs (1:1 binding fitted curves are overlaid as black lines).dATP
insertion efficiency results of (a) 8-mer to 9-mer and (b) 11-mer to 12-mer in control,
G1*G2T-FABP and G1G2*T-FABP, respectively, in 10 min.
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TABLE LEGENDS
Table 1. Steady-state kinetics parameters for insertion of dCTP opposite unmodified
and FABP−dG adduct with Kf-exo−.
Table 2. SPR binding affinities, KD (nM) of unmodified (TG1G2T) and FABP−dG
adducts (TG1[FABP]G2T and TG1G2[FABP]T) with Kf-exo− (steady-state affinity
analysis) in the binary and ternary systems. Association and dissociation rate constants,
ka and kd, in binary system are listed.
Table 3. Binding net stabilization energy of unmodified and FABP-adducts with Kfexo− in binary system (1:1 binding).
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Table 1:
Sequence

Km (µM)

kcat (min-1)

kcat/Km (µM-1·min-1)

*fins

FABP-G1

23.4

29.7

1.27

0.33

Control-G1

7.4

28.8

3.87

1.00

FABP-G2

5.7

5.5

0.97

0.24

Control-G2

5.8

23.2

4.00

1.00

*fins= (kcat /Km)modified/(kcat /Km)unmodified control.
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Table 2:
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Table 3:

*Net stabilization energy (kcal/mol)= -RTln(kd)modified – [-RTln(kd)unmodified]
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ABSTRACT
Oligonucleotides serve as important tools for biological, chemical, and medical research.
The preparation of oligonucleotides through automated solid-phase synthesis is well
established. However, identification of byproducts generated from DNA synthesis,
especially from oligonucleotides containing site-specific modifications, is sometimes
challenging.

Typical HPLC, Mass Spectrometry (MS), and gel electrophoresis

methods alone are not sufficient for characterizing unexpected byproducts, especially
for those having identical or very similar molecular weight (MW) to the products. We
used a rigorous quality control procedure to characterize byproducts generated during
oligonucleotide syntheses: 1) purify oligonucleotide by different HPLC systems; 2)
determine the exact MW by high resolution MS; 3) locate modification position by
MS/MS or exonuclease digestion with MALDI-TOF analysis; and 4) conduct, where
applicable, enzymatic assays. We applied these steps to characterize byproducts in the
syntheses of oligonucleotides containing important methyl DNA adducts 1methyladenine (m1A) and 3-methylcytosine (m3C).

In m1A synthesis, we

differentiated a regioisomeric byproduct 6-methyladenine, which possesses identical
MW to m1A. As for m3C, we identified a deamination byproduct 3-methyluracil, which
is only 1 Dalton greater than m3C in the ~ 4,900 Dalton context. The detection of these
byproducts would be very challenging if the abovementioned procedure were not
adopted.
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INTRODUCTION
Oligonucleotides synthesized chemically are widely used as drugs and research tools in
biology, chemistry, and medicine.

Solid phase synthesis of DNA and RNA

oligonucleotides has been well developed and automated phosphoramidite-based
chemical process has become highly efficient.1–3 Phosphoramidites of regular and some
modified nucleotides are commercially available and certain oligonucleotide strands
could be readily obtained from commercial sources.4–7 Besides the great development
in the synthesis of oligonucleotides, the differentiation of byproducts from the product
oligonucleotides, especially on those containing site-specifically modified structures, is
sometimes ignored by the end users. If those byproducts or small impurities were not
identified and removed, it could have devastating consequences for the corresponding
biological assays and medical treatments.8,9 For certain instances, it is challenging to
identify some byproducts generated in the synthesis and deprotection steps, especially
those byproducts that have identical or very similar MW to the desired product
oligonucleotide.
We have synthesized various oligonucleotides containing modified structures in
the past, focusing on alkyl or aryl DNA adducts, by using solid and solution phase DNA
synthesis.10–14 In the syntheses of oligonucleotides containing 1-methyladenine (m1A)
and 3-methylcytosine (m3C), we observed byproducts are either regioisomer (identical
MW) to the product or have 1 Dalton in MW greater than the product in a ~ 4,900 Dalton
context (Figure 1a).

m1A and m3C are formed by exogenous and endogenous

alkylating agents mainly in single-stranded DNA and have been detected both in vitro15–
21

and in vivo15,20,22–29. Both adducts are cytotoxic and block DNA replication, and are
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the best substrates for the AlkB family DNA repair enzymes (Figure 1b).30–34 m3C has
also been proposed an epigenetic biomarker for cancer. 35
Most of our DNA syntheses successfully provided target oligonucleotides.
However, some oligonucleotides contained side reaction contaminants generated during
the synthesis or deprotection steps, requiring further purification and identification. To
that end, we applied a rigorous quality control process which entails the following steps:
i) Synthesize an adduct-containing oligonucleotide from the corresponding
phosphoramidite; ii) purify the product oligonucleotide by both reverse phase and anion
exchange HPLC; iii) measure the exact MW of the oligonucleotide by high resolution
MS (HR-MS), certain impurities can also be detected by HR-MS; iv) determine the
modification position by either MS/MS or exonuclease digestion with MALDI-TOF
analysis; and v) test the biological activity of the adduct-containing oligonucleotide by
appropriate enzymatic assays. We are assuming that the modified nucleotide has been
extensively investigated for its stability under solid-phase chemical synthesis and
deprotection beforehand; however, the strategy outlined above should confirm this.
Nuclear Magnetic Resonance (NMR; 1H, 13C, and 31P) is a powerful tool for structural
integrity studies of the phosphoramidite on the milligram scale.36–38 However, NMR
becomes impractical for characterizing minor impurities within the modified structures
in synthetic oligonucleotides due to increasing spectral complexity, as well as the final
amount of material available (e.g. on a micro-mole or less scale). Below, we report the
detailed characterization of byproducts in the syntheses of oligonucleotides containing
m1A and m3C. The characterization and separation of those byproducts provides
confidence in the quality of oligonucleotides used in further biological experiments.
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RESULTS
Identification of m6A Byproduct from m1A Synthesis.

We were trying to

incorporate m1A into an oligonucleotide as a substrate for the AlkB repair reaction. 34,39
A 16mer oligonucleotide containing m1A was prepared by using the commercially
available phosphoramidite of m1A (Figure 1a). The final product was deprotected
under standard conditions by treating the crude oligonucleotide with ammonium
hydroxide at 80 ℃ for 3h. The oligonucleotide was then tested by both reverse phase
and anion exchange HPLC (see Experimental Procedures for detailed conditions). The
resulting chromatograms showed a single peak under both conditions (retention time
10.2 min in Figure 2a and 4.0 min in Figure S22). High resolution ESI-TOF MS
analysis of the sample exhibited m/z at 1224.715 at its -4 charge state, which is in good
agreement with the theoretical m/z 1224.711 expected of the product oligonucleotide
(Figure 3a, S1 and Table 1).
Collision-induced-dissociation (CID) MS/MS analysis was used to determine
the location of the alkyl adduct in the synthesis of m1A-containing 16mer
oligonucleotide (Figure 4). The MS/MS results, presented in detail in the supporting
information (Figures S5 and Tables S1), confirmed that modification occurred at the
eighth position from the 3’ end of the oligonucleotide and the modified base had the
same MW as m1A. Analysis of 3’ end fragmentations indicated that w 15 to w8 fragments
all contain an extra methyl modification (Figure 4, Table S1 and Figure S10). On the
other hand, w7 to w1 ions showed only standard DNA sequences without methyl
modification (Table S1). These results suggested the modification is located between
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w8 and w7, which is the eighth position from the 3’ end of the 16mer oligonucleotide.
From the 5’ fragmentations, we observed the methyl modification in ions from (a 15-C)
to (a10-G), but no such modification from ion (a9-X) to (a2-A) (Figure 4, Figure S9 and
Table S1). These results suggested the modification is located between (a 10-G) and (a9X), which is the ninth position from the 5’ end (Figure 4). The fragmentation patterns
from both the 5’ and 3’ ends are consistent with the proposed m1A-containing DNA
sequence (Figure 4).
To further confirm the location of the modified base, we performed enzymedigestion coupled with MALDI-TOF MS analysis.11–13,40,41 The procedure has been
widely used to confirm the location of lesion positions by determining the mass changes
after partial digestion from the 3’ end by the exonuclease SVP. 42–44 Figure 5 shows the
positive ion MALDI-TOF MS spectra of the 3’ to 5’ SVP exonuclease digestion of the
product oligonucleotide at different time intervals. The m/z of 4904.2 at 0 min (before
digestion, as a control) indicated the 16mer DNA sequence contained a methylated
DNA base (theoretical m/z = 4902.9 Dalton, herein theoretical m/z values are shown in
parentheses after the observed m/z values). After 1 minute SVP digestion, while the
product ion disappeared, three new lower masses appeared at m/z = 4615.7 (4614.8),
4326.7 (4325.8), and 4022.7 (4021.7), which correspond to the 15, 14, and 13mer
fragments generated from 3’ cleavage, respectively (Figure 5). The signal intensity of
three new peaks were significantly increased with the disappearance of the original
product oligonucleotide ion at m/z = 4904.2.
Further digestion resulted in a number of smaller fragments. In 3 min digestion
(Figure 5 and S17), the signal of m/z = 3075.1 (3074.6) matches the sequence for the
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fragment that was cleaved one base before the lesion. The m/z = 2746.4 (2745.5,
containing a methyl modification), represents the digestion occurring on the 3' side of
the modified adenine position (Figure 5), which also persisted in the 5 min digestion
spectrum. The signal at 2419.1 (2418.5, no methyl modification) in the 3 and 5 min
digestions

represents

the

fragment

generated

after

liberation

of

the

deoxymethyladenosine 5' monophosphate. Digestions practically stopped at m/z =
1223.6/8 (1222.3), which represent the m/z of a 4mer nucleotide of the 5’ end. Taken
together, these results confirm that the modified structure is a methylated adenine and
it is at the ninth position of the proposed oligonucleotide from the 5’to 3’ direction.
The chromatographic and mass spectral evidence presented above indicates that
the product oligonucleotide could have the MW expected for a 16mer containing the
m1A adduct in the correct position. We then tested the repair of this product by the
AlkB protein, which is an enzyme that repairs various alkylated DNA adducts (Figure
1b).32,34 The result showed the repair efficiency of this oligonucleotide by AlkB was
very low, even when 2.5 uM of AlkB was incubated with 5.0 uM product
oligonucleotide (Figure 6b and Figure S24). This observation was in contrast to the
report that m1A is a good substrate of AlkB (eg. 0.2 µM of AlkB is able to repair 5.0
µM m1A completely in 1 h).10

We suspected that the structure in the product

oligonucleotide may not be m1A, even though it had an identical MW to m1A. The
reverse phase HPLC results also showed an anomalous phenomenon. For example, the
positively charged m1A nucleobase34 should be more polar than the natural base adenine
and thus have a shorter retention time on a C18 column. However, the opposite was
observed: adenine has a shorter retention time than the product (Figure 2a and 2c). It
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has been reported that 6-methyladenine (m6A) could be generated from a Dimroth
rearrangement of m1A under basic conditions(Figure 1a and Table 1). 34,45
We therefore conducted a new batch synthesis of m1A under a milder
deprotection condition (25 ℃ for 16 h). The product oligonucleotide was eluted as a
single peak in both HPLC columns (Figure 2b for C18 and Figure 6d for anion
exchange). The HPLC retention time in reverse phase HPLC exhibited a shorter
retention time (8.5 min, Figure 2b) than the non-modified control adenine (9.0 min,
Figure 2c) or the previous product (10.2 min, m6A, Figure 2a), in good agreement with
the theory that m1A should be more polar than both A and m6A.
The MW of the new product was characterized by HR-MS and had the correct
m/z of m1A at 1224.715 (1224.711) (Figure 3b, S2 and Table 1). The MS/MS results
(e.g., the w7, w8, a9-X, and a10-G ions, Figure 4, Figure S6, S11, S12, and Table S2)
demonstrated the modification is at the ninth position from the 5’ end and it is a
methylated adenine. The exonuclease digestion with MALDI-TOF analyses (Figure
S18 and S21a) also confirmed the location and identity of adduct. For example, the
2746.1 (before adduct) and 2418.8 (after adduct) peaks at 3 min digestion in Figure S18
were present. Finally, incubation with AlkB showed an excellent repair efficiency
against the new product oligonucleotide: 5.0 µM adduct was mostly repaired in 1 hr
with 0.2 µM enzyme (Figure 6e).10 Taken together, these results confirmed the newly
synthesized product as a 16mer oligonucleotide containing m1A at the ninth position
from the 5’ end (Figure 1a).
Identification of m3U Byproduct from m3C Synthesis. We also wanted to synthesize
an oligonucleotide containing m3C as the substrate for the AlkB family DNA repair
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reactions within the same sequence context as for the m1A oligonucleotide (Figure
1a).34,39 After automated synthesis and standard deprotection (80 ℃ for 3h), the HPLC
chromatogram from a C18 column showed two peaks with similar intensities (9.5 min
and 11.6 min, Figure 2d), which were readily separated (Figure 2e and 2f). HR-MS
analysis showed that the early eluting peak (9.5 min, Figure 2e) had an m/z value
1218.703 at -4 charge state (Figure 3c and S3), which is in agreement with that of the
m/z of the target m3C containing oligonucleotide (theoretical m/z 1218.709, Table 1).
The second species at 11.6 min (Figure 2f) showed an m/z 1218.957 at its -4 charge state
(Figure 3d and S4). Compared to the 9.5 min peak, the m/z value of the second species
was 0.254 unit higher at the -4 charge state, indicating that the MW (4,879.850 Dalton)
of the second species is 1.016 Dalton higher than the first one. This is consistent with
the m/z value of an oligonucleotide containing m3U at its -4 charge state (1218.955,
Table 1). m3U could potentially be generated from deamination of m3C under basic
conditions (Figure 1a).46 The MS/MS results of the two oligonucleotides (e.g., the w7,
w8, a9-X, and a10-G ions, Figure 4, Figure S7, S8, S13 to S16, Table S3, and S4)
demonstrated the modifications are at the ninth position from the 5’ end.

The

exonuclease digestion with MALDI-TOF analyses (Figure S19, S20 and S21b) also
confirmed the location and identity of the adducts. At 7 minute digestion, signature
peaks were 2722.2 (before adduct) and 2418.8 (after adduct) for m3C (Figure S18); and
2723.3 (before adduct) and 2418.7 (after adduct) for m3U (Figure S19). The C18 HPLC
retention time of the two species showed m3C containing oligonucleotide had a shorter
retention time (9.5 min, Figure 2e) than m3U (11.6 min, Figure 2f). This result indicated
m3C is more polar than m3U, which supports that m3C is positively charged at pH 7.0
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(Figure 1a).34 The AlkB reaction (0.2 µM) on the m3C oligonucleotide showed a good
repair efficiency: 5.0 µM m3C adduct was mostly repaired to cytosine after 1 h (Figure
6h). This was not the case for m3U containing oligonucleotides under a similar
condition, which showed almost no repair to m3U (Figure 6k). These observations were
consistent with the observations that m3C is a strong substrate but m3U is a weak
substrate for AlkB under both in vitro and in vivo conditions.34,47
To avoid the formation of m3U, we carried out a second batch synthesis of m3C
containing oligonucleotide under a milder deprotection condition (25 ℃ for 16 h). This
time we observed only the m3C containing species in the HPLC chromatogram (similar
to Figure 2e). The identity of the newly synthesized m3C was confirmed by the
aforementioned spectroscopic and enzymatic tests. These results indicate that the
formation of the byproduct m3U was from deamination of m3C catalyzed by harsh
deprotection conditions (high temperature and alkaline).46,47

Serendipitously, the

formation of m3U in the first batch of synthesis provides a new method for chemically
preparing m3U-containing oligonucleotide.

DISCUSSION
Chemical synthesis of oligonucleotides is important for conducting various biological,
chemical, and medical research including oligonucleotide drug development. The field
of oligonucleotide synthesis has progressed such that DNA and RNA containing
standard bases can be ordered from commercial sources. Most of these oligonucleotides
are in high quality, but it is a good practice to perform quality control in order to confirm
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the products have the correct sequences in high purity. A simple HPLC/MS analysis
should be sufficient for most applications. However, a more rigorous and stringent
quality control procedure48–50 should be adopted for site-specifically modified
oligonucleotides, such as epigenetic marks, DNA adducts, and drug candidates. In some
cases, byproducts are generated from side chemical reactions during standard automated
synthesis and deprotection steps. For this reason, specific deprotection conditions may
be required for preparation of oligonucleotide containing modifications, such as
epigenetic biomarkers: 5-hydroxymethyl-dC, 5-formyl-dC, and 5-carboxy-dC. 51,52
After synthesis and deprotection, it is even more important to carry out a thorough
purification and characterization procedure to ensure 1) complete removal of protecting
groups, 2) product having high purity, and 3) modification having the correct position
and identity. In this study, we used a reliable and robust procedure to characterize
byproducts from m1A and m3C syntheses.
m6A, a byproduct of m1A synthesis, exhibited identical MW and location to
m1A. It is difficult to differentiate m1A and m6A without conducting bioassays and
careful HPLC retention analysis. As for m3C, it was the m3U byproduct that showed a
1 Dalton difference in the ~ 4,900 Dalton context (Table 1). The two oligonucleotides
could be eluted as a single species in HPLC under certain conditions, thus it is
imperative to perform high resolution MS analysis and enzymatic reaction to distinguish
the two products.

For HPLC analysis of modified oligonucleotides, we used a

combination of two different separation systems, such as reverse phase (e.g. C18) and
anion exchange chromatography. For example, it is not easy to find a suitable condition
for fully separating 16mer containing m1A and A with C18 columns (Figure 2b and 2c).
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However, it is relatively easy to separate them with an anion exchange column, since
m1A is positively charged at neutral pH but A is not (Figure 1a, 6d and 6f).34 On the
other hand, it is not easy to distinguish m6A and A under anion exchange condition
(Figure S22 and S23) because of their neutrality at pH 7.0, but it is possible to separate
them on the C18 column (Figure 2a and 2c).
The MW of the oligonucleotide can be determined by HR-MS, and the location
of the modification can be identified by MS/MS or exonuclease digestion with MALDITOF analysis. To further confirm the identity of the oligonucleotide from a biological
activity perspective, we recommend running enzymatic reaction on the product. In this
work, we used SVP exonuclease to digest all oligonucleotides formed in the syntheses.
A specific enzyme for certain types of modification could greatly help elucidate the
structure of modification. So we tested the repair efficiency of m1A and m3C and their
byproducts by the AlkB repair enzyme.32,34 The AlkB protein in E. coli is an αketoglutarate/Fe(II)-dependent dioxygenase that repairs various alkyl DNA adducts,
including m1A and m3C (Figure 1).30–32,39,53–55 We found that m1A and m3C are good
substrates but m6A and m3U are weak substrates of AlkB.34,47,53 For other modified
structures, it is highly recommended that a biological or enzymatic assay should be
adopted for identifying the product. The reason for adopting an enzymatic test is
because a byproduct (e.g. m6A) may have an identical MW as the target product (e.g.
m1A), which may be hard to differentiate by LC and MS analyses, including the MS/MS
and exonuclease digestion with MALDI-TOF analysis.

EXPERIMENTAL SECTION
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Synthesis of Oligonucleotides Containing m1A and m3C. Oligonucleotides (16mer)
with the sequence 5’-GAAGACCTXGGCGTCC-3’ containing the lesions at X position
were made by using solid-phase phosphoramidite chemistry on a MerMade-4
Oligonucleotide Synthesizer.10,34,56

The phosphoramidites were purchased from

ChemGenes. The final cleavage and deprotection step was usually carried out by
treating the oligonucleotide with concentrated aqueous ammonium hydroxide (28%) at
80 ℃ for 3 hours. The modified cleavage and deprotection step for minimizing the
byproduct formation was at 25℃ for 16 h. The concentration of an oligonucleotide was
determined by measuring UV absorbance at 260 nm. The extinction coefficient (ε) of
a certain adduct is calculated as its unmodified counterpart due to the slight variation
between the values in the context of a 16mer DNA.
Purity Test of Oligonucleotides Containing m1A and m3C and Related
Byproducts by HPLC. The purity of oligonucleotides was tested by both reverse phase
(C18) and anion exchange HPLC methods. For the reverse phase test, liquid
chromatographic separation was performed by using a Phenomenex Luna SemiPreparative C18 column (9 x 250 mm, 5 µm) at a flow rate of 3 mL/min. Solvent A
was 100 mM triethylammonium acetate in water and solvent B was 100% acetonitrile.
A solvent gradient was carried out under the following conditions: 2.0% of B for 0.2
min, 2.0 to 9.0% of B over 0.3 min, 9.0 to 9.4% of B over 16 min, 9.4 to 70.0% of B
over 0.5 min, 70.0% of B for 3 min, 70.0 to 2.0% of B over 0.5 min, and 2.0 % B over
4.5 min. The column oven was set at 40 ℃. The UV signal at 260 nm was used to detect
the oligonucleotide absorbance. For the anion exchange LC analysis, oligonucleotides
were purified and tested by using a Thermo DNAPac PA-100 anion exchange column
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(4 x 250 mm, 13 µm) with solvent A as water and solvent B as 1.5 M ammonium acetate
in water. A solvent gradient was carried out under the following conditions: 50.0% of
B for 1 min, 50.0 to 52.0% of B over 2 min, 52.0 to 75.0% over 1 min, 75.0% of B for
2 min, 75.0 to 50.0% of B over 0.5 min, and 50.0% of B for 4.5 min. The flow rate was
at 4.0 ml/min.
HPLC-MS Analysis. High resolution MS analyses of oligonucleotides were
performed on AB Sciex triple quadrupole-TOF mass spectrometers (ABI4600 and
ABI5600). ESI was conducted by using a needle voltage of 4.0 kV in a negative ion
mode. A heated capillary was set at 600 ℃. The nebulizer gas pressure was 40 psi;
the heater gas pressure was 40 psi; the curtain gas pressure was 25 psi; the declustering
potential was -220 V; and the collision energy was -10 V. Liquid chromatographic
separation was performed using a Phenomenex Luna C 18 column (4.6 × 100 mm; 5
µm) at a flow rate 0.4 mL/min. Solvent A was 10 mM ammonium acetate in water and
solvent B was 100% acetonitrile. A solvent gradient was carried out under the following
conditions: 2.0% of B for 0.5 min, 2.0 to 17.4% of B over 11min, 17.4 to 60.0% of B
over 0.1 min, 60.0% of B for 2 min, 60.0 to 2.0% of B over 0.1 min, and 2.0 % B over
3.3 min.
MS/MS Analysis. Oligonucleotide fragmentation analyses were performed by
manually injecting the oligonucleotide samples of 100 pmol/µl into AB Sciex triple
quadrupole-TOF mass spectrometers (ABI4600 and ABI5600). The syringe flow rate
was set at 10 µl/min. ESI was conducted by using a needle voltage of 4.5 kV in a
negative ion mode. A heated capillary was set at 400 ℃. The nebulizer gas pressure
was 75 psi; the heater gas pressure was 25 psi; the curtain gas pressure was 25 psi; the
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declustering potential was -100 V; and the collision energy was -15 V. The parent ion
m/z for m6A, m1A, m3C and m3U were selected as 816.14 (-6 charge), 816.14 (-6
charge), 974.77 (-5 charge) and 974.96 (-5 charge), respectively. Data analyses were
performed with the AB Sciex Analyst TF software 1.7.
Exonuclease Digestion with MALDI-TOF Analysis.

The modified

oligonucleotides were characterized by 3’-5’exonuclease digestion followed by
MALDI-TOF analysis. In general, 1.0 μL of sample containing 200-250 pmol of a
modified oligonucleotide was used for digestion. SVP (0.2 unit) was added together
with 6.0 μL of ammonium citrate (100 mM, pH 9.4) and 6.0 μL of water for the 3′ to 5′
digestion.11 For the MALDI-TOF analyses, 1.0 μL of the mixture was used at a certain
time point until the digestion was almost finished; the digestion was quenched by
mixing with 1.0 μL of MALDI analysis matrix (3-hydroxypicolinic acid and diammonium hydrogen citrate in a 1:1 ratio). Samples were analyzed by a Shimadzu
Axima Performance MALDI-TOF mass spectrometer using a 50Hz laser with a power
setting of 90 in positive ion reflection mode with 500 shots collected. 13
Enzymatic Reaction with the AlkB protein and HPLC Analysis.

All

reactions were performed at 37 ℃ for 1 h in a reaction buffer containing 70.0 μM
Fe(NH4)2(SO4)2·6H2O, 0.93 mM α-ketoglutarate, 1.86 mM ascorbic acid, and 46.5 mM
HEPES (pH 8.0).10 The reactions were quenched by adding 10.0 mM EDTA followed
by heating at 95 ℃ for 5 min. Typically, 0.25 µM of the purified AlkB protein was
incubated with 5.0 µM m6A and m1A in the presence of all cofactors in a 20 μL reaction
volume. For the m3C and m3U, 0.18 µM of AlkB was incubated with 5.0 µM of
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oligonucleotides. Samples were then analyzed under an HPLC condition that was able
to separate the substrate and product.
To separate the starting material and product of the enzymatic reactions for the
four lesions, different HPLC conditions were optimized by using either C18 or anion
exchange columns. The UV detection was set at 260 nm. Specifically, (1) m6A and its
repaired product A were analyzed by using a Phenomenex Luna Semi-Preparative C18
column (10 x 150 mm, 5 µm) under the following conditions: Solvent A was 100 mM
triethylammonium acetate in water and solvent B was 100% acetonitrile. A solvent
gradient was carried out under the following conditions: 2.0% of B for 0.2 min, 2.0 to
9.0% of B over 0.3 min, 9.0 to 9.4% of B over 16 min, 9.4 to 70.0% of B over 0.5 min,
70.0% of B for 3 min, 70.0 to 2.0% of B over 0.5 min, and 2.0 % B for 4.5 min. The
flow rate was at 3.0 ml/min. The column oven was set at 40 ℃. This protocol was also
used to analyze m3U and its repair product U. (2) m1A and its repaired product A were
analyzed by using a Thermo DNAPac PA-100 anion exchange column (4 x 250 mm, 13
µm) with solvent A as water and solvent B as 1.5 M ammonium acetate in water. A
solvent gradient was carried out under the following conditions: 50.0% of B for 1 min,
50.0 to 52.0% of B over 2 min, 52.0 to 75.0% over 1 min, 75.0% of B for 2 min, 75.0
to 50.0% of B over 0.5 min, and 50.0% of B for 4.5 min. The flow rate was at 4.0
ml/min. (3) m3C and its repaired product C were analyzed with a similar protocol to
m1A/A analysis, except the solvent gradient was changed to the following conditions:
50.0% of B for 1 min, 50.0 to 57.0% of B over 1 min, 57.0% of B for 2 min, 57.0 to
50.0% of B for 0.5 min, then 50.0% of B for 4.5 min.
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FIGURE LEGENDS
Figure 1. Oligonucleotide products and byproducts studied in this work.

a) the

structures of adducts and byproducts from chemical syntheses and b) the alkyl adduct
m1A, as an example, is repaired in the presence of the AlkB enzyme and necessary
cofactors.
Figure 2. Reverse phase HPLC chromatograms of 16mer DNA alkyl products and
byproducts. The retention time of a modification-containing oligonucleotide is labeled
on top of the corresponding chromatogram. The modifications are: a) m6A); b) m1A;
c) A; d) mixture of m3C + m3U; e) m3C; and f) m3U.
Figure 3. High resolution ESI-TOF MS analyses of 16mer DNA oligonucleotides
containing target modifications and byproducts. Data represent the -4 charge envelopes
and the monoisotopic peak (all 12C, 14N, etc.) values are labeled above the first peak
in each peak envelope. a) The oligonucleotide (containing m6A) generated from initial
m1A synthesis; b) m1A; c) m3C; and d) m3U.
Figure 4. Predicted fragmentation pattern from collision-induced-dissociation of the
16mer oligonucleotide products from the m1A and m3C syntheses. X denotes the
modified nucleotides.
Figure 5. Time-course MALDI-TOF analyses of SVP digestion products of the 16mer
product oligonucleotide (containing m6A) generated from m1A synthesis. Theoretical
masses are listed in the inset.

The theoretical monoisotopic mass at 2745.5 is

126

highlighted in red because it is the smallest digestion product containing the
modification.
Figure 6. HPLC profiles of the AlkB repair reactions on different alkyl substrates. The
three chromatograms within each panel represent one set of repair reaction including
the oligonucleotides of starting material, reaction mixture, and product. For example,
in the panel containing chromatograms a, b, & c, a) represents the starting material m6A,
b) represents the repair reaction of m6A by AlkB, and c) represents the pure product
adenine synthesized separately. Chromatograms shown in a, b, & c relevant to m6A
repair and in j, k, & l relevant to m3U repair were analyzed under reverse phase
conditions. Chromatograms shown in d, e, & f relevant to m1A repair and in g, h, & i
relevant to m3C repair were analyzed under anion exchange conditions (see
Experimental Procedures for detailed information). a) m6A; b) m6A+AlkB; c) A; d)
m1A; e) m1A+AlkB; f) A; g) m3C; h) m3C+AlkB; i) C; j) m3U; k) m3U+AlkB; and l)
U.
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TABLE LEGENDS
Table 1:
Calculated and observed monoisotopic molecular weight and m/z value of modified
oligonucleotides. For m1A and m3C synthesis, the sequence of the 16mer was 5’GAAGACCTXGGCGTCC-3’, where X indicates the position of the modified bases.
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Table 1:
MW (calculated)

m/z (calculated)

m/z (observed)

of neutral species

-4 charge peak

-4 charge peak

16mer m6A

4902.877

1224.711

1224.715

16mer m1A

4902.877

1224.711

1224.715

16mer m3C

4878.866

1218.709

1218.703

16mer m3U

4879.850

1218.955

1218.957

Lesion or base
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